View
5
Download
0
Category
Preview:
Citation preview
CURRICULUM VITAE January 5th, 2014
1
Name: ROBERT C. G. MARTIN, II, MD, PHD
Office address: Division of Surgical Oncology
University of Louisville
315 East Broadway, #313
Louisville, KY 40202
Phone: (502) 629-3355
Fax: (502) 629-3030
E-mail: Robert.Martin@louisville.edu
Home address: 3705 Pennington Lane
Louisville, KY 40207
Date of Birth: May 16, 1968
Place of Birth: Louisville, Kentucky
Marital Status: Married: Sarah P. Martin, MeD
Children: Cora H. Martin
Clare V. Martin
Christine J. Martin
Education: Georgetown University 1986-1990
Major: Mathematics
Washington, DC
Degree: BSc
University of Louisville School of Medicine 1991-1995
Louisville, Kentucky
Degree: MD
University of Louisville School of Medicine 2003-2008
Department of Pharmacology and Toxicology
Louisville, KY
Degree: PhD
Endowed Professorship: Sam and Lolita Weakley Endowed Chair 2011- Present
in Surgical Oncology
Department of Surgery
University of Louisville
Faculty Appointments: Graduate Research Training Faculty 10/13-Present
CURRICULUM VITAE January 5th, 2014
2
Member of the Graduate Faculty
University of Louisville School of Medicine
Associate Professor of Pharmacology & 9/2013-Present
Toxicology
University of Louisville School of Medicine
J. Graham Brown Cancer Center
Professor of Surgery 7/2011-Present
University of Louisville
Department of Surgery
University of Louisville
Louisville, KY
Director 4/2008-Present
Division of Surgical Oncology
Department of Surgery
University of Louisville
Louisville, KY
Associate Professor of Surgery 7/2007-6/2011
Division of Surgical Oncology
University of Louisville
J. Graham Brown Cancer Center
Assistant Professor of Surgery 7/2002- 6/2007
Division of Surgical Oncology
University of Louisville
J. Graham Brown Cancer Center
Internship: University of Louisville Hospital 1995-1996
Louisville, Kentucky
Surgery
Residency: Department of Surgery 1996-1999
University of Louisville School of Medicine
Louisville, Kentucky
Chief Administrative Resident: Department of Surgery 1999-2000
University of Louisville
Louisville, Kentucky
CURRICULUM VITAE January 5th, 2014
3
Fellowship: Surgical Oncology Fellow 2000-2002
Memorial Sloan Kettering
Hepatobiliary Fellow 2001-2002
Memorial Sloan-Kettering
Certification: American Board of Surgery - #46569 10/29/2001
Recertified 12/11/2010
Licensure: Kentucky- #32503
New York - #218879
Honors/Awards: Charles M. Edelen Award
Best Publication by a Resident 2000
John W. Price Award
Excellence in undergraduate instruction 2000
William L. Brohm Award
Outstanding Overall Performance Resident 2000
Career Development Award
The Society for Surgical of the Alimentary Tract 2004-2006
Hiram C. Polk, Jr. Surgical Award
Resident Education chosen by the graduating
Chief Residents 2006
Nominated “Faculty Favorite”
Delphi Center for Teaching/Learning 2007
America’s Top Surgeon
Best Doctor 2007-2008 2008
Patients' Choice Award
Nation's most beloved doctors, patients 2008
2009 Top Doctors
Louisville Magazine! 2009
Who’s Who in America 2009
2009 Patients Choice Physician 2009
CURRICULUM VITAE January 5th, 2014
4
Cancer Liaison Physician (CLP)
Outstanding Performance Award 2010
America’s Top Oncologist
Honor of Distinction and Excellence 2010
America’s Most Compassionate Doctors 2010
America’s Top Surgeons 2011-2012 2011-2012
Best Doctors
Louisville Magazine 2012, 2013
Alpha Omega Alpha Honor Medical 2012
Society
Best 2011 JOGS Best Article Award Winner 2012
Analysis of 6,747 Pancreatic Neuroendocrine
Tumors for a Proposed Staging System
69th Samuel David Gross Lectureship 2013
Chemoprevention in Esophageal and
Hepatocellular Cancer
National Committees:
Southeastern Surgical Congress 1998
Continuing Medical Education Comm 2009-2013
Chair Program and CME Committee 2013-2014
Society of American Gastrointestinal
Endoscopic Surgeons 1998
American Medical Association 1991
American Hepato-Pancreato-Biliary Association 2002
Membership Committee 2005-2007
Development Committee 2007-present
International Relations Committee 2008-present
Chair, Professional and Development 2010-2012
Committee
Executive Council Member 2010-Present
CURRICULUM VITAE January 5th, 2014
5
International Hepato-Pancreatico-Biliary
Association 2009-present
Corporate Relations Committee 2009
The Society for Surgery of the Alimentary Tract 2000
Hepatobiliary Program Committee 2010
The Society of Surgical Oncology 2000
Training Program Directors Subcommittee 2006
Website Committee 2008
Chair of the Corporate Relations Committee 2009-Present
Continuing Medical Education Committee 2009
Chair of the Needs Assessment/Practice 2011-2013
Gaps Workgroup
Executive Council Member 2013-2016
James Ewing Foundation
Treasurer 2011-Present
The American Society of Clinical Oncology 2000
American Association for Cancer Research 2002
American College of Surgeons Oncology Group
Physician Group Leader 2003
Fellow 2004
Member 2000
Association for Academic Surgery 2004
The Leadership Council 2008-2010
Ethics Committee 2011-2013
The Society of University Surgeons 2005
The Membership Committee 2010-2013
The Western Surgical Association 2005
The Southwestern Surgical Congress 2008
The Southern Surgical Association 2008
The Central Surgical Association 2008
Program Committee 2012-Present
CURRICULUM VITAE January 5th, 2014
6
The American Association Surgical Association 2012
The Cholangiocarcinoma Foundation Medical
Advisory Committee 2013
Local/State: Jefferson County Medical Association 1995-present
Georgetown Alumni Admissions 1998-present
University of Louisville School of Medicine
Admissions Committee 1992-1995
Graduate Medical Committee House Staff
Council 1999-2000
Kentucky Medical Association 1991-present
Manpower Committee 1991-1994
Cancer Committee 2002-present
Chairman 2006-present
Hiram C. Polk Surgical Society 2000-present
Secretary 2009-present
Louisville Surgical Society 2002-present
President 2011
Cancer Liaison University of Louisville Hospital 2002-present
James Graham Brown Cancer Center
Cancer Committee 2002-present
Chair Subcommittee: 2003 BCC Annual Report 2004
Chair Subcommittee: Conferences 2004-present
Cancer Prevention and Control Program 2003-present
Physician in Charge Tumor Board 2002-present
The American Cancer Society
Colorectal Screening Committee 2003-present
Kentucky Physician’s Workgroup 2004-Present
Norton Health Care
Director Upper Gastrointestinal & Hepato-
Pancreatico-Biliary Conference Norton Hospital 2004-present
CURRICULUM VITAE January 5th, 2014
7
Cancer Liaison Norton Hospital
Committee on Cancer 2002-present
Cancer Liaison Outstanding Performance
Award 2010
Leadership: Network Designation Committee
on Cancer 2005-2006
Physician Advisory Committee
Colonoscopy Screening Initiative 2006-present
Norton Cancer Institute Advisory Board 2007-present
Center for Genetics and Molecular Medicine:
Genetic Susceptibility and Biomarkers Core 2004-present
Director Upper Gastrointestinal and
HepatoPancreaticoBiliary
Multidisciplinary Clinic and Conference
James Graham Brown Cancer Center 2005- present
University of Louisville
Resident Conference Director 2005-Present
University of Louisville Hospital
Medical Staff Bylaws Committee 2006
Director of Surgical Resident Curriculum 2005-2010
Co-Director Surgical Oncology Journal Club for
Surgical Residents 2004-Present
Director Upper Gastrointestinal and Hepato-
Pancreatico- Biliary Multidisciplinary Clinic
and Conference James Graham Brown Cancer
Center 2005-Present
Co-Director of the Society of Surgical Oncology
Accredited 2-Year Surgical Oncology
Fellowship Program 2005-Present
One Hour Lectures on Liver and Spleen to Third Year
Medical Students Each 8-Week Surgery Rotation 2002-2010
CURRICULUM VITAE January 5th, 2014
8
One Hour Lecture on Pancreas to Third
year Medical Students Each 8-Week
Surgery Rotation 2002-2010
Participate in Third Year Oral Exams Each
8-Week Surgery Rotation 2002-Present
Journal Club for Senior Honors Students 2003
Mentoring:
Name of
Mentees
Medical Student,
Resident, Fellow,
Pre- or Post-doc Training Period Prior Academic Degree Title of Research Project(s) Current Position
Ryaz Chagpar Pre 6/25/2005 to
9/1/2005
BS
MSc
2003 University of
Saskatchewan
Factors associated with
improved survival among
young adult melanoma
patients despite a greater
incidence of sentinel lymph
node metastasis.
Surgical Resident,
University of
Vancouver, British
Columbia
Angela Michelle
Lewis
Post 07/01/05 to
06/30/07
BS
MD
1999
2000
Temple University Analysis of DNA adducts
and DNA damage in
thyroid disease and thyroid
cancer
Private practice, The
Portland Clinic,
Oregon, Surgical
Oncology
Charles E. Woodall Post 07/01/06 to
06/30/08
BLA
MD
Dec 2000
May 2001
University of
Missouri-Kansas
City
Accurate nodal staging and
imaging characteristics to
predict overall survival
Instructor, Endoscopy
(ERCP), Department
of Surgery,
University of
Louisville, Kentucky
Nathan Reuter Post 07/01/2007 to
06/30/2009
BA
MD
May 1998
May 2002
University of North
Dakota
Use of adjuvant
chemotherapy in young
women with node-negative
ER+ breast cancer: refining
the use of recurrence score -
a decision analysis.
Current Surgical
Oncology Fellow,
Source of Support is
James Graham Brown
Cancer Center,
Louisville, Kentucky
Matthew R. Bower Post 07/01/2008 to
06/30/2010
BS
MD
May 1999
June 2003
University Texas
Southwestern
Chemoprotective Effects of
Curcumin in Esophageal
Epithelial Cells Exposed to
Bile Acids
Current Surgical
Oncology Fellow,
Source of Support is
James Graham Brown
CURRICULUM VITAE January 5th, 2014
9
Cancer Center,
Louisville, Kentucky
Christine Landry Post 7/1/2004 to
7/1/2008
MD (resident) 2008 University of
Louisville
Analysis of carcinoid
tumors
Surgical Oncology
Fellow, MD
Anderson, Houston,
Texas
Harini Aiyer Post 2007-2011 PhD 2007 University of
Kentucky
Prevention of reflux-
induced esophageal
adenocarcinoma by dietary
berries
Research Postdoc,
Georgetown
University
Yan Li Post 2003-current MD, PhD 1998 Cheng Du University
of Chinese Medicine
Optimal Esophageal
Animal Modeling
Current Assistant
Clinical Professor of
Research
Division of Surgical
Oncology
Kalista Hughes Med Student 6/1/03-8/15/03 BS 5/2002 UL MnSOD and Gastric Cancer Internal Medicine
Resident
Amanda Bressler PGY1 7/1/07 to 6/30/08 M.D.
BS
5/2007
2002
UL
UK
MnSOD expression in
Pancreatic Cancer
Ob/Gyn Resident –
Good Samaritan -
Cincinnati, Ohio
Ryan Duvall Med Student 6/1/2007-
8/15/2007
BS 5/2005 UL
Jennifer Lohle Med Student 6/1/2006-
8/15/2006
BS 5/2004 UL Kentucky Hepatoma:
epidemiological variant or
same problem different
region?
Ob/Gyn Resident –
Good Samaritan -
Cincinnati, Ohio
Ryan Whitney Med Student 1st-4th 6/15/2008-
Present
BS 5/2007 UL The Use of Self-Expanding
Silicone Stents in
Esophageal Strictures: Less
Cost and More Efficiency
Current Third Year
Medical Student
Jonathan Joshi Post Med School 1 6/1/2008-7/1/2009 MD 5/2008 UL Hepatic Intra-arterial
injection of Irinotecan Drug
Eluting Beads in
Unresectable Colorectal
Liver Metastatic Refractory
to Standard Systemic
Chemotherapy: Results of
PGY-1 Department of
Radiology
CURRICULUM VITAE January 5th, 2014
10
Multi-Institutional Study
Bruce Herrmann Res 07/1/02 to
6/30/07
M.D.
BS
2002
1998
Texas Tech
Baylor University
Association of Manganese
Superoxide Dismutase
Expression with
Progression of
Carcinogenesis in Barrett’s
Esophagus.
**Charles M. Edelen
Award Winner: Best
publication by a resident.
Plastic Surgery
Fellowship – UT
Chattanooga (07-09)
Vedra Augenstein Res
07/1/05 to
6/30/10
MD
BS
2005 UL
UL
The Quality of Survival
Reporting in Chemotherapy
and Surgery Trials in
Metastatic Colorectal
Cancer.
**Publication: Cancer
2006;106:1389-1394.
PGY-5 Chief Surgical
Resident
Sebastian Eid Res
07/1/05 to
6/30/10
MD
BS
2005
2001
UL
UL
Assessment of symptom
experience in patients
undergoing hepatic
resection or ablation.
**Publication: Cancer
2006;107:2715-2720.
PGY-5 Chief Surgical
Resident
Chinmaya Shelgikar Res 7/1/ 2001 to
6/30/07
(research year at
Emory 7/04
to7/05)
MD
BS
2001
Medical College of
Wisconsin
Univ of Wisc, Mad
Empiric Antibiotics for
Transarterial Embolization
in Hepatocellular
Carcinoma: Indicated?
**Publication: Am Surg
2007
Private Practice, Ann
Arbor, MICH
Benjamin Vessels Res 7/1/2008 –
5/15/2009
BS 2003 UL The role of esophageal
stents in the nutritional
support of patients with
esophageal malignancy
Resident
Russell Brown Fellow 7/1/2009 –
1/1/2010
MD Theramal Resistance
Effects of Hepatocellular
Second Yr Surg Onc
Fellow UL
CURRICULUM VITAE January 5th, 2014
11
Cancer
Nick Harper Undergraduate 5/3/2010 –
8/15/2010
BS – Pending 2011 Bellarmine EGFR expression in
Barrett’s Esophagus
Daniel Malik Undergraduate 5/15/2009 –
5/5/2010
BS – Pending 2011 UL MnSOD expression in
smoke exposed Barrett’s
Esophagus
Andrew Ramsey Medical Student 1st 6/1/2010 –
8/12/2010
MD- Pending 2014 UL BMI as a predictor of
outcomes following
pancreatectomy
Suzanne Schiffman Resident – PGY3
Research Fellow
7/1/2009 –
6/30/2010
MD 2007 U of Pitt Intrahepatic
Cholangiocarcinoma and
molecular predictors of
ourcome
Surg Onc Research
Fellow
Charles R. St. Hill Surgical Oncology
Fellow
7/1/2010 –
6/30/2012
MD 2005 U Nevada Las Vegas Efficacy of LEDC Ablation
on Human Pancreatic
Adenocarcinoma in a
Murine Model
Assistant Professor of
Surgery UNLV
Russell Farmer Resident – PGY3 7/1/2010-
6/30/2011
MD 2004 U of Texas Surg Onc Research
Fellow
Mohsen Hasanin Medical Student 11/1/2010 –
12/31/2010
MD 2010 Cairo University Surgical Oncology
outcomes
Surg Onc Medical
Student rotation
Amanda Miller Medical Student 5/14/2011-
8/12/2011
BS 2004 Quality if life after major
hepatectomy
Second Year Medical
Student
Nsehniitooh Mbah Medical Student 5/14/2011-
4/12/2014
BS 2004 3 publications: Optimal
Transection for
Laparoscopic Liver
Second Year Medical
Student
Robert M Cannon Resident – PGY 2 –
Research
3/4/2011 –
6/30/2012
MD 2007 U of Georgia 5 Publications:
Laparoscopic Liver
Resection
Third Year Surgical
Resident
Thomas Lee Resident – PGY 2 –
Research
5/4/2011-
6/30/2012
MD 3 Publications: Quality
Factors in Readmission
following Surgical
Oncology Procedures
Third Year Surgical
Resident
Matthew Fox Resident – PGY3 –
Research
5/5/2010-
6/30/2011
MD 3 Publications: Optimal
Surgical Outcomes in
Pulmonary Carcinoids
Fourth Year Surgical
Resident
CURRICULUM VITAE January 5th, 2014
12
Eric Dunki-Jacobs Surgical Oncology
Fellow
7/1/2011-
6/30/2012
MD U of Cincinnati First Year Surgical
Onc Fellow
Rafi Kotoyan Third Year Medical
Student
5/5/2011-
12/2/2012
MD Hepatic Arterial Therapy in
Met Pancreatic Cancer
General Surgery
Resident UNLV
Scott Tatum Third Year Medical
Student
5/5/2011 –
12/2/2012
BS
MD
2012
U of Louisville
Hepatic Arterial Therapy in
Met GE Junction Cancer
Radiology Resident
Rhodes Brown Undergraduate 6/2012-8/2012 BS (pending) 2013 William and Lee
College
Optimal Management of
Liver Dominant Breast
Cancer
Undergrad Student
Nicholas Burnett First Year Student 6/2012-8/2012 BS
MD
2011
2015
U of Louisville
Optimal Staging in HCC
Pubs Below:243
R25 NIH Summer
Student
Ryan Anderson First year Student 6/2012-8/2012 BS
MD
2011
2015
U of Louisville
Pancreatic fistula
prevention with
somatostatin
R25 NIH Summer
Student
Vanessa States Undergraduate 6/2012- 8/2012 BS R25 NIH Summer
Student
Jacob Edwards First Year Medical
Student
9/12 to 5/13 BS 2011 Combined Liver and
Pancreatic Resections:
Safety and Outcomes
Elizabeth
Bruenderman
First Year Student 6/2013-5/2014 BS Optimal Pancreatic
Screening and Cost for
Pancretic Adenocarcinoma
Prevention
R25 NIH Summer
Student
Alan North First Year Student 6/2013-5/2014 BS 2012 Microwave Ablation:
Optimal quality and
presentation
R25 NIH Summer
Student
John Wehry First Year Student 6/2013-5/2014 BS 2012 Allogenic Blood
Transfusion in Surgical
Oncology
R25 NIH Summer
Student
Xuanyi (Selina) Li Pre-Doctoral Student 6/2011-6/2014 BS 2010 Ohio State
University
Berry Gavage and Liver
protection
Dental Student
Alexandria Oliver Pre-Doctoral 1/2014-7/2015 BS 2012 Mercer University PK data for DEBDOX use Masters
Biophysiology
Dissertation Committee Work:
Chair Dissertation Committee for
2008 Masters Program: 2008
CURRICULUM VITAE January 5th, 2014
13
Charles W. Woodall, MD: Research proposal
Yttrium-90 Intra-Arterial Brachytherapy
for Unresectable Hepatocellular Cancer with Portal
Vein or Inferior Vena Cava Thrombosis:
Safe and Clinically Beneficial?
Member Dissertation Committee for
2008 Masters Program: 2008
Benjamin Vessels, MD: Research Proposal
The Multidisciplinary Use of Esophageal Stenting
Mentor of PhD Doctoral Candidate Pharmacology
and Toxicology: Harshul Pandit 2013-
Present
Clinical Service Activities: Director Upper Gastrointestinal and Hepato
Pancreatico-Biliary Multidisciplinary Clinic
And Conference
James Graham Brown Cancer Center 2005-
Present
Establishing an specialized practice in Upper
Gastrointestinal and Hepato-Pancreatico-Biliary
Cancers with RVU average billing of
15,750 per year (> 95% benchmark averages for
Surgeons) 2002-
Present
Established TheraSphere program for
Unresectable Hepatocellular Cancers and
Compassionate Use for Metastatic Cancers
To Liver 2004-
Present
Established the only intraoperative MRI-guided
Liver ablation center in the region 2002-2005
Established only Microwave Ablation Center in
Region 2003-
Present
CURRICULUM VITAE January 5th, 2014
14
Established only LC Bead, Drug-Eluting Bead
Treatment Center in region 2005-
Present
Course Director: Laparoscopic Liver
Resection Course – Nine visiting surgeons
From the United States attended to learn my
Technique of laparoscopic liver resection November
9, 2007
Invited Faculty: Advanced Upper Abdominal
& Bowel Cadaver Surgery
Instructed 17 gynecologist oncologists in
Hepatic resection, ablation and bowel resection
Techniques May 17-
18, 2008
Course Director: First Ever Microwave Ablation
Course: Basic physics Preoperative, intraoperative
And Postoperative techniques
Twenty visiting surgeons and interventional
Radiologists/oncologists from the United States April 15,
2008
Attended to learn my technique of microwave June 20,
2008
Ablation – Three separate courses August 15,
2008
Course Director: Microwave Ablation and
Ultrasound Workshop
Trained 21 separate surgeons on advanced
Hepatic ultrasound and microwave ablation July 22-24,
2009
Course Director of the Only Irreversible
CURRICULUM VITAE January 5th, 2014
15
Electroporation Physician Training Workshop:
2009: October 10th, 2009, November 11th, 2009,
2010: February 12th, 2010, February 19th, 2010, March 26th,
2010, May 7th, 2010, May 21st, 2010, Sept 4th, 2010, Oct
15th, 2010, Nov 3rd, 2010, Nov 12th, 2010, Dec 17th, 2010,
2011: 1/7, 2/11,2/22, 3/1, 3/25,5/20, 6/17, 7/8, 8/26, 9/30,
10/14, 11/4, 12/9
- Total trained 95 Surgeons/ Interventional Oncologist from the
United States and Taiwan on the Pre-Clinical, Clinical, and
Hands on Use of Irreversible Electroporation in the Non-
Thermal Soft Tissue Ablation
2012: 1/13, 2/24, 5/18, 5/25, 6/19, 8/24, 10/5, 11/16, and 12/14
- Total of 100 Surgeons/ Interventional Oncologist from the
United States and Taiwan on the Pre-Clinical, Clinical, and
Hands On Use of Irreversible Electroporation In the Non-
Thermal Soft Tissue Ablation
2013: Jan, Feb, March, April, May, June, July, August, Sept,
Oct, Nov, and Dec
- Total of 75 Surgeons/ Interventional Oncologist from the
United States and Taiwan on the Pre-Clinical, Clinical, and
Hands On Use of Irreversible Electroporation In the Non-
Thermal Soft Tissue Ablation
Course Director of the Only Irreversible Electroporation
Human Case Observations:
2010: Aug 4th, 2010, Sept 22nd, 2010, Oct 13th, 2010, Nov
3rd, 2011, Dec 1st, 2010
2011: 7/27, 8/24, 9/7, 9/28, 10/12, 11/2, 12/7
-Total of 60 Surgeons trained the actual use and safety of the
device from The United States, France, and Japan
2012: 1/11, 2/29, 5/23, 7/11, 8/22, 9/26, 10/24, 11/14, and
12/12
-Total of 45 Surgeons trained the actual use and safety of the
device from The United States
2013 : Jan, Feb, March, April, May, June, July, August, Sept,
Oct, Nov, and Dec
- a total of 48 Surgeons from USA, Denmark, Czech Republic,
and other European Countries trained for the Actual use and
Safety of the Device in the United States : Jan, Feb, March,
April, May, June, July, August, Sept, Oct, Nov, and Dec
- a total of 48 Surgeons trained for the Actual use and Safety of
the Device in the United States
CURRICULUM VITAE January 5th, 2014
16
Co-Course Director of Laparoscopic Liver, Pancreatic, Gastric
and Esophageal Surgery Human Case Observation Course:
2012:
- Total of 12 Surgeons from across the United States have
traveled to observe and learn minimally invasive techniques for
laparoscopic liver, pancreatic, gastric and esophageal
resections.
RESEARCH FUNDING:
Grants Completed
1. Role: Principal Investigator 3/13/2003 Codman: Johnson and Johnson
Unrestricted Educational Grant for Hepatobiliary Disease Management Team and
Screening. $15,000
2. Role: Principal Investigator 7/1/2003-6/30/2004
James Graham Brown Cancer Center: Cancer Research Pilot Projects.
Genetic Polymorphisms in Manganese Superoxide Dismutase (MnSOD) as a Predictor
of Lung Cancer. $31,596.
3. Role: Principal Investigator 7/1/2003-6/30/2004
James Graham Brown Cancer Center: Microarray Pilot Project Program.
Expression Profiles of Barrett’s Esophagus using Laser Capture Microdissection:
Evaluating Predictors for Malignancy. $30,000.
4. Role: Principal Investigator 7/1/2004-6/30/2006
Society for the Surgery of the Alimentary Tract: Career Development Award.
Oxidative Stress in the Progression of Barrett’s Esophagus to Adenocarcinoma
Utilizing a Novel External Esophageal Perfusion Model. $80,000.
5. Role: Co- Investigator 7/1/2004-6/30/2006
Pharmacogenetics of drug and carcinogen metabolism.
Activities to Promote Research Collaborations: supplement to NCI parent
grant (R01-CA34627). $113,750.
6. Role: Principal Investigator 5/1/2006 – 9/30/2006
James Brown Cancer Center MicroPet Pilot Project
Evaluation of Barrett’s Metaplasia and Esophageal Adenocarcinoma by Micro-PET
Scan in Esophagoduodenal Anastomosis Rat Model. $30,000.
7. Role: Principal Investigator 7/1/2006 – 10/30/2006
CURRICULUM VITAE January 5th, 2014
17
School of Medicine Grant
MnSOD Therapy in the prevention of adenocarcinoma in a rat model of
Barrett’s esophagus. $15,000.
8. Role: Principal Investigator 10/1/2008 to 9/30/2010
NIH RO3 CA137801-01
Prevention of Reflux Induced Esophageal Adenocarcinoma by Dietary
Berries. $145,000
9. Role: Principal Investigator Robert C.G. Martin 7/1/2010 – 12/31/2011
CLINICAL AND TRANSLATIONAL SCIENCE PILOT GRANT PROGRAM
Title of Innovative Award: Validated Animal Model to Identify Novel Predictors
of Barrett's Progression into Cancer $175,000
10. Role: Co-Principal Investigator 3/29/2010 to 4/30/2012
Wallace H Coulter Foundation
Chitosan Modified NIR Absorbing gold nanoparticles for increasing efficacy of
treatment of hepatocellular cancer $240,000
Current Grant Funding & Clinical Trials
1. Role: Principal Investigator 7/1/2007 to Present
Unrestricted Education Grant: AngioDynamics/ Biocompatibles
Evaluation of Precision Hepatic Arterial Therapy for Primary and Metastatic
Liver Tumors $1,650,000.
2. Role: Sponsor – Principal Investigator Co-Investigator 6/1/2010 – 6/30/2010
Biocompatibles Foundation
Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Unresectable
Intrahepatic Cholangiocarcinoma (ICC) with Concomitant Systemic Gemcitabine and
Cisplatin (Gem-Cis)
Pilot $32,100
Initial Phase 2: $126,000
Second Phase 2: $640,000
3. Role: Principal Investigator 10/1/2010 to Present
Unrestricted Education Grant: AngioDynamics/ Biocompatibles
Evaluation of Soft Tissue Ablation for Cancers $950,000
4. Role: Participating Faculty Mentor (PI: Hein DW)
University of Louisville Cancer Education Program
CURRICULUM VITAE January 5th, 2014
18
Funding Agency: NIH/NCI (R25-CA134283)
Project Period: September 14, 2011 to August 31, 2016
5. Role: Martin (PI) (Biocompatibles, Investigator Initiated) - 4/18/2009-12/31/2014
FDA: IDE Submission #G080230-S001
Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis from
Colon Cancer with Concomitant Systemic Oxaliplatin, Fluorouracil and Leucovorin
chemotherapy, and anti-Angiogenic Therapy
Phase 1: $188,000
Phase 2: $1,250,000
6. Role: Martin (PI) (Sirtex Initiated Phase III Study) – 6/2006 to Present
Prospective Randomized Phase 3 Trial using Folfox-based chemotherapy in
combination with SirSphere® liver-directed radiation therapy to treat metastatic
colorectal cancer.
Phase III - $265,000
7. Role: Martin (PI) (MDS Nordion Phase II Study) – 1/2013 to Present
TS-102 trial is a randomized phase III study evaluating the use of Yttrium-90
drug eluting beads in combination with standard of care chemotherapy
(FOLFOX or FOLFIRI) versus chemotherapy alone.
Phase II - $295,000
8. Role: Martin (PI) (MDS Nordion Phase III Study) – 1/2013 to Present
This randomized phase III trial will evaluate the overall survival of Yttrium-90
drug-eluting beads in combination with sorafenib versus sorafenib alone in the
treatment of patients with unresectable hepatocellular carcinoma.
Phase III - $195,000
9. Role: Martin (PI)Investigator Initiated Study - 1/2013 to Present
GERD-Related Symptom Assessment in Subjects with Malignant Dysphagia
Receiving Esophageal Stents.
Pilot - $9000
Longer Term Study: $9000
Completed Clinical Trials
10. (Biocompatibles, Investigator Initiated) Martin (PI) - 10/1/2009-8/2012
FDA: IDE Submission #G090097/S001
Transcatheter arterial chemoembolization (TACE) with doxorubicin-loaded LC
beads in the treatment of liver metastases in patients with stage IV metastatic
melanoma: A multicenter pilot non-randomized, feasibility trial $467,000
CURRICULUM VITAE January 5th, 2014
19
11. (Bayer, Industry Sponsored) Martin (PI) - 9/1/2009-6/2012
A Phase III randomized, double-blind, placebo-controlled study of sorafenib as adjuvant
treatment for hepatocellular carcinoma after surgical resection or local ablation”
(the “STORM – Adjuvant HCC study”) $197,000
12. (Bayer, Industry Sponsored) Martin (PI) - 3/1/2009-6/1/2011
HCC Non-Interventional Study –GIDEON
$65,000
13. (Investigator Initiated) Martin (PI) - 4/18/2009-12/31/2011
Clinical Evaluation of Neoadjuvant Gemcitabine, Docetaxel, and capecitabine
with Concurrent Radiation for Patients with Borderline/ Locally Advanced
Pancreatic Carcinoma
(Unfunded)
14. (ACOSOG Cooperative Group) Martin (PI) - 5/1/2009-12/31/2011
A phase II study of preoperative and postoperative gemcitabine and erlotinib
for patients with operable pancreatic adenocarcinoma.
15. (ACOSOG Cooperative Group) Martin (PI) - 5/1/2009-12/31/2011
A phase II study of neoadjuvant therapy with cisplatin, docetael, panitumunab
plus radiation therapy followed by surgery in patients with locally advanced
adenocarcinoma of the distal esophagus.
16. (Industry Sponsored, Investigator Initiated) Martin (PI) - 6/1/2008-12/31/2010
Clinical Evaluation of Polyflex Stenting in Esophageal Cancer patients Undergoing
Chemotherapy and/or Radiation therapy
$118,000
17. (Industry Sponsored, Investigator Initiated) Martin (PI) - 6/1/2008-6/30/2010
FDA: IND Submission (Martin) #08.0119 (NCT00955097)
Evaluation of intra-operative ultrasound contrast enhancement in the evaluation of liver
Tumors
(Unfunded)
18. (Industry Sponsored, Investigator Initiated) Martin (PI) - 3/1/2008-12/31/2010
FDA IND Submission (Martin) #CR012460, EPOSUR4005
A prospective, randomized, double blinded control study or procrit vs placebo to determine
efficacy in pre-operative patients undergoing major surgical oncology procedures. $129,000
19. (Industry Sponsored) Martin (PI) - 10/11/2008-12/31/2010
CURRICULUM VITAE January 5th, 2014
20
Selective Internal Radiation Therapy (SIRT) + 5-Fluorouracil, Leucovorin and OXaliplatin
[FOLFOX6m] vs. FOLFOX6m alone
$197,588
20. (Investigator Initiated) Martin (PI) - 5/1/2009-12/31/2010
Effect of Reinforced Staple Line on Leak Rate in Distal Pancreatectomy
(Unfunded)
21. (Investigator Initiated) Martin (PI) - 4/3/2004- 8/2012
TheraSphere Hepatocellular Humanitarian Device Exemption Programs and Compassionate
Use Metastatic to Liver Program
(Unfunded)
22. (Investigator Initiated) Martin (PI) - 12/1/2002-8/30/2003
Evaluation of Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy.
23. (Investigator Initiated) Martin (PI) - 7/1/2006-6/30/2009
Norton Healthcare Community Trust Fund.
Phase I/II Evaluation of Intraoperative Autotransfusion Filtration for Major Surgical
Oncology Operations.
$150,000.
24. (Vivant Medical, Investigator Initiated) Martin (PI) - 1/4/2004-10/31/2004
A Phase II study of Microwave Hepatic Ablation: Safety and Efficacy.
$50,000
25. (Zymogenetics, Industry Sponsored) Martin (PI) - 3/5/2004-10/15/2004
A Phase 2, Randomized, Double-Blind Study of the Safety and Efficacy of Topical
rhThrombin in Subjects Undergoing Partial Hepatectomy.
$110,000
26. (Zymogenetics, Industry Sponsored) Martin (PI) - 3/5/2006-6/15/2006
A Phase 3, Randomized, Double-Blind, Controlled Study of the Safety and Efficacy of
Topical rhThrombin (1000 U/mL) in Surgical Hemostasis.
$188,000
27. (University of Calgary, Investigator Initiated) Martin (PI) - 7/9/2007-6/30/2008
Randomized Control Trial Comparing the Effectiveness of a Web Based Journal Club
to a Standard Journal Club Format to Teach Critical Appraisal Skills.
$2000
Editorial Boards: The American Surgeon 2005-Present
CURRICULUM VITAE January 5th, 2014
21
Annals of Surgical Oncology 2009-Present
World Journal of Gastroenterology 2009-Present
Contributing Associate Editor-in-Chief 2011-Present
International Journal of Surgical Oncology 2009-Present
HPB 2010-Present
The American Journal of Surgery
Journal of Gastrointestinal Surgery
2012- Present
2011-Present
Invited Reviewer: American Journal of Surgery 1998-2005
Annals of Surgery 2008
Annals of Surgical Oncology 2005-Present
BMC Cancer 2006
Cancer Control: Journal of the Moffitt Cancer
Center
2005
Clinical Chemistry and Laboratory Medicine 2005
Clinical Cancer Research 2008
Cancer 2008
Critical Reviews in Oncology/Hematology 2006
Digestive and Liver Disease 2007
European Journal of Surgical Oncology 2006-Present
Endocrine Related Cancer 2006
Future Oncology 2006
International Journal of Cancer 2006
Journal of the American College of Surgeons 2002-Present
Journal of Surgical Research 2003
Journal of Clinical Oncology 2006
Medical Science Monitor 2005-2006
Mutation Research 2009
Southern Medical Journal 2002
Surgery 2006-Present
The American Surgeon 2004-Present
World Journal of Surgical Oncology 2007-Present
Peer-Reviewed Publications:
1. Spain DA, Martin RCG, Carrillo EH, Polk HC Jr. Twelfth rib resection: Preferred therapy
for subphrenic abscess in selected surgical patients. Arch Surg 132:1203-1206, 1997.
2. Seligson D, Howard PA, Martin RCG. Difficulty in removal of certain intramedullary
nails. Clin Orthop 340:202-206, 1997.
CURRICULUM VITAE January 5th, 2014
22
3. Flynn MB, Amin EA, Martin RCG. Mobile mammography screening: The James Graham
Brown Cancer Center three year experience. J KY Med Assoc 96:17-20, 1998.
4. Flynn MB, Greenwell D, Martin RCG. Value of preoperative localization studies prior to
initial neck exploration for hyperparathyroidism. J KY Med Assoc 97:255-260, 1999.
5. Martin RCG, Flynn MB. Initial neck exploration for untreated hyperparathyroidism. Am
Surg 66:269-272, 2000.
6. Martin RCG, Edwards MJ, Cawte TG, Sewell CL, McMasters KM. Basosquamous
carcinoma: Analysis of prognostic factors influencing recurrence. Cancer 88:1365-1369,
2000.
7. Martin RCG, Stutz JP. Multiple granular cell tumors of the gallbladder and biliary tree:
Literature review and case report. Gastrointest Endosc 51:238-240, 2000.
8. Martin RCG, Edwards MJ, McMasters KM. Giant cell tumor of tendon sheath,
tenosynovial giant cell tumor, and pigmented villonodular synovitis. Oncol Rep 7:413-419,
2000.
9. Martin RCG, McMasters KM, Wong SL, Tuttle TM, Edwards MJ. Optimal gamma probe
detection of sentinel lymph nodes in breast cancer: Results of a nationwide multi-institutional
study. Surgery 128:1-6, 2000.
10. Reed DS, Martin RCG, Vitale GJ. Bile duct carcinoma: Trends in treatment in the nineties.
Am Surg 66:711-715, 2000.
11. Flynn MB, Greenwell D, Martin RCG, Cerrito PB. Safety and effectiveness of methylene
blue infusion for intraoperative identification of parathyroid glands. J Surg Invest 3:227-233,
2001.
12. Martin RCG, McMasters KM. Presentation of histoplasmosis as an isolated liver lesion:
Case report and review. Am Surg 5:430-431, 2001.
13. Klodell CT, Martin RCG, Allen JW, Polk HC. Value of an advanced surgical technology
experience in the basic education of general surgical residents. Bulletin American College of
Surgeons 86:11-15, 2001.
14. Martin RCG, DeRossis AM, Fey J, Yeung H, Yeh SDJ, Akhurst T, Heerdt AS, Petrek J,
VanZee KJ, Montgomery LL, Borgen PI, Cody HS. Intradermal isotope injection is superior
to intramammary in sentinel node biopsy for breast cancer. Surgery 130:432-438, 2001.
CURRICULUM VITAE January 5th, 2014
23
15. McMasters KM, Wong SL, Martin RCG, Chao C, Tuttle TM, Noyes RD, et al. Dermal
injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel
lymph node biopsy: Results of a multi-institutional study. Ann Surg 233:676-687, 2001.
16. Martin RCG, Fong Y, Dematteo RP, Blumgart LH, Jarnagin WR. Peritoneal washings are
not predictive of advanced stage in hilar cholangiocarcinoma. J Am Coll Surg 193:620-625,
2001.
17. Martin RCG, Fey J, Borgen PI, Cody HS. Highest isotope count does not predict sentinel
node positivity in all breast cancer patients. Ann Surg Oncol 8:592-597, 2001.
18. Martin RCG, Jarnagin WR. Randomized Clinical Trials in Hepatocellular Carcinoma and
Biliary Cancer. Surg Oncol Clin North Am, Jan, 11:193-205, 2002.
19. Martin RCG, Klimstra D, Brennan MF, Conlon KC. Solid-pseudo papillary tumors of the
pancreas: A surgical enigma. Ann Surg Oncol 9:35-40, 2002.
20. Martin RCG, Vitale GC, Reed DN, Larson GM, Edwards MJ, McMasters KM. Cost
comparison of endoscopic stenting versus surgical treatment for unresectable
cholangiocarcinoma. Surg Endosc 16:667-670, 2002.
21. Martin RCG, Spain DA, Richardson JD. Do facial fractures protect the brain or are they a
marker for severe head injury? Am Surg 68:478-481, 2002.
22. Martin RCG, Jaques DP, Brennan MF, Karpeh M. Achieving RO resection for locally
advanced gastric cancer: Is it worth the risk of multi-organ resection? J Am Coll Surg,
194(5), 568-577, 2002.
23. Martin RCG, Brennan MF, Jaques DP. The quality of complication reporting in the surgical
literature. Ann Surg 235:803-813, 2002.
24. McMasters KM, Chao C, Wong SL, Martin RCG, Edwards MJ. Sentinel lymph node
biopsy in patients with ductal carcinoma in situ: a proposal. Cancer 95:15-20, 2002.
25. Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RCG,
McMasters KM. C-terminal deletion mutant p21 (WAF1/CIP1) enhances E2F-1-mediated
apoptosis in colon adenocarcinoma cells. Cancer Gene Ther 9:453-463, 2002.
26. Martin RCG, Jaques DJ, Brennan MF, Karpeh M. Extended local resection for advanced
gastric cancer: Increased survival vs increased morbidity? Ann Surg 236:159-165, 2002.
27. Martin RCG, Klimstra D, Jarnagin WR, Blumgart LH. Hepatic intraductal oncocytic
CURRICULUM VITAE January 5th, 2014
24
papillary neoplasm. Cancer 95: 2180-2187, 2002.
28. Martin RCG, Jarnagin WR. Peripheral/Intrahepatic Cholangiocarcinoma: Current
Management. Minerva Chirurgica 58, 469-478, 2003.
29. Martin RCG, Antonescu C, Brennan MF. Adult soft tissue Ewing sarcoma and primitive
neuroectodermal tumors: Is age an adverse predictor of survival? Arch Surg 138: 281-285,
2003.
30. Martin RCG, Jarnagin W, Fong Y, Blumgart L, DeMatteo RP.The Use of Fresh Frozen
Plasma After Major Hepatic Resection For Colorectal Metastasis, Is there a standard for
transfusion? J Am Coll Surg, 196, 402-409, 2003.
31. Martin RCG, Paty P, Fong Y, Grace AW, Cohen A, DeMatteo RP, Jarnagin W, Blumgart
LH. Synchronous Colorectal Liver Metastasis: Staged or Simultaneous Resection? J Am Coll
Surg, 197, 233-242, 2003.
32. Martin RC, Polk HC, Jr., Jaques DP. Does additional surgical training increase participation
in randomized controlled trials? Am J Surg 2003; 185:239-243.
33. Chao C, Abel T, Martin RCG, McMasters KM. Intraoperative Frozen Section of Sentinel
Nodes: A Formal Decision Analysis. Am Surg, 2004;70(3):215-220.
34. D'Angelica M, Martin RCG, Jarnagin WR, Fong Y, DeMatteo RP, Blumgart LH. Major
hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. J Am
Coll Surg 2004;198(4):570-576.
35. Palmer L, Martin RCG, Hein DW. Chemopreventive drug treatment in subjects with
genetic predisposition to cancer: prescriber liability and health care disparities.
Pharmacogenetics. 2004; 5(3):319-329.
36. Chagpar A, Pilavas J, Chao C, Martin RCG, McMasters KM. Sentinel lymph node biopsy
for breast cancer: addressing the controversies. Cancer Therapy 2003, 1:223-232.
37. Chagpar A, Martin RCG, Chao C, Wong, SL, Edwards MJ, Tuttle T, McMasters KM.
Validation of subareolar and periareolar injection techniques for breast sentinel lymph node
biopsy. Arch Surg 2004; 139(6):614-618.
38. Chao C, Martin RCG, Ross MI, Reintgen DS, Edwards MJ, McMasters KM. Correlation
Between Prognostic Factors and Increasing Age in Melanoma. Ann Surg Onc 2004, 11(3),
259-264.
CURRICULUM VITAE January 5th, 2014
25
39. Chagpar A, Martin RCG, Hagendoorn LJ, Chao C, McMasters KM. Lumpectomy margins
are affected by tumor size and histologic subtype but not by biopsy technique. Am J Surg
188(4), 399-402, 2004.
40. D'Angelica M, Martin RC, Jarnagin WR et al. Major hepatectomy with simultaneous
pancreatectomy for advanced hepatobiliary cancer. J Am Coll Surg 2004; 198:570-576.
41. Hughes KH, Kelty S, Martin RCG. Hepatoid Carcinoma of the Pancreas. American Surgeon
70, 130-133, 2004.
42. Martin RCG, Hughes K, Doll MA, Lang Q, Martini B, Chow W, Lissowska J, Zatonski W,
Rothman N, Hein DW. Method for Determination of (-102C>T) Single Nucleotide
Polymorphism in the Human Manganese Superoxide Dismutase Promoter. BMC Genetics
5:33, 2004.
43. Edwards MJ, Broadwater R, Tafra L, Jarowenki D, Mabry C, Beitsch P, Whitworth P,
Martin RCG, Oetting L. Progressive adoption of cryoablation therapy for breast
fibroadenoma in community practice. Am J Surg 188, 221-224, 2004.
44. Martin RCG. Intraoperative Magnetic Resonance Imaging Ablation of Hepatic Tumors: A
Surgeon’s Perspective. Am J Surg 189, 388-394, 2005.
45. Martin RCG, Edwards MJ, McMasters KM. Morbidity of Adjuvant Hepatic Arterial
Infusion Pump Chemotherapy in the Management of Colorectal Cancer Metastatic to the
Liver. Am J Surg 188(6), 714-721, 2004
46. Sholar A, Martin RCG, McMasters KM. Popliteal Lymph Node Dissection. Ann Surg Onc
12(2), 189-193,2005.
47. Martin RCG, Hughes K, Doll MA, Lang Q, Martini B, Chow W, Lissowska J, Zatonski W,
Rothman N, Hein DW. No Apparent Association between MnSOD (-9) and MnSOD (-102)
Genotypes and Risk of Gastric Cancer. J of Surg Res 124, 92-97, 2005.
48. Martin RCG, D’Angelica M, Blumgart LH. Papillary Low Grade Neuroendocrine Tumor of
the Pancreas with Pancreatic Duct Dilation. Archives of Surgery 140(3), 311-312, 2005.
49. Li Yan, Wo J, Su R, Ray MB, Jones W, Martin RCG. Esophageal Injury with a Novel
External Esophageal Perfusion. J Surg Res 129 (1), 107-113, 2005.
50. Martin RCG, Chagpar A, Scoggins CS, Edwards MJ, Hagendoorn L, Stromberg AJ,
McMasters KM. Clinicopathologic Factors Associated With False Negative Sentinel Lymph
Node Biopsy in Breast Cancer. Ann Surg 241(6), 1005-10012, 2005.
CURRICULUM VITAE January 5th, 2014
26
51. Martin RCG, Kehdy FJ, Allen JW. Formal Training in Advanced Surgical Technologies
Enhances the Surgical Residency. Am J Surg 190(2), 244-248, 2005. \
52. Chagpar AB, Martin RCG, Scoggins CR, Carlson DJ, Laidley AL, El-Eid SE, McGlothin
TQ, Noyes RD, Ley PB, Tuttle TM, McMasters KM. Factors Predicting Failure to Identify a
Sentinel Lymph Node in Breast Cancer. Surgery 138, 56-63, 2005.
53. Scoggins CR, Chagpar AB, Martin RCG, McMasters KM. Should sentinel lymph-node
biopsy be used for staging melanoma and breast cancers? Nature Clinical Practice Oncology
2(9), 448-455, 2005.
54. Conn CA, McMasters KM, Edwards MJ, Martin RCG. Acceptance of Sentinel Lymph
Node Biopsy of the Breast by All General Surgeons in Kentucky. The Breast Journal 11(4),
231-235, 2005.
55. Herrman B, Li Y, Ray M, Wo J, Martin RCG. Association of Manganese Superoxide
Dismutase Expression with Progression of Carcinogenesis in Barrett’s Esophagus. Archives
of Surgery 140(12), 1204-1209, 2005.
56. Martin RCG, Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Edwards MJ, McMasters
KMM. Is Incisional Biopsy of Melanoma Harmful? Am J Surg 190(6), 913-917, 2005.
57. Hutchinson JR, Chagpar AB, Scoggins CR, Martin RCG, McMaster KM. Surgeon and
community factors affecting breast cancer sentinel lymph node biopsy. Am J Surg 2005;
190:903-906.
58. Martin RCG, Wellhausen SR, Moehle DA, Martin AW, McMasters KM. Evaluation of
Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy. Ann Surg
Onc 12 (12) 1017-1024, 2005.
59. Martin RCG, Scoggins, CR, McMasters KMM. A Phase II Study of Radiofrequency
Ablation of Unresectable Metastatic Colorectal Cancer with Hepatic Arterial Infusion Pump
Chemotherapy. J Surg Onc 2006; 93(5):387-393.
60. Martin RCG, Augenstein VA, Scoggins CR, McMasters, KM. The Quality of Survival
Reporting in Chemotherapy and Surgery Trials in Metastatic Colorectal Cancer. Cancer 106
(6) 1389-1394, 2006.
61. Chagpar AB, Scoggins CR, Sahoo S, Martin RCG, McMasters KM. Biopsy type does not
influence sentinel lymph node status. Am J Surg 2005; 190:551-556.
CURRICULUM VITAE January 5th, 2014
27
62. Chagpar AB, Kehdy F, Scoggins CR, Martin RCG, McMasters KM. Effect of
lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast
cancer. Am J Surg 2005; 190:557-562.
63. Li Y, Ray M, Koopman J, Wo JM, Martin RC Cycloxygenase -2 and Epithelial Growth
Factor Receptor up-Regulation during Progression of Barrett's Esophagus to
Adenocarcinoma. World J Gastroenterol, 12(6) 928-934, 2006.
64. Martin RCG, Studts JL, McGuffin SA, Roetzer LM, Abell TA, McMasters KM. Method of
Presenting Oncology Treatment Outcomes Influences Patient Treatment Decision-making in
Metastatic Colorectal Cancer. Ann Surg Onc 13(1), 86-95, 2006.
65. Chagpar AB, Studts JL, Scoggins CR, Martin RCG, Carlson DJ, Laidley AL, El-Eid SE,
McGlothin TQ, Noyes RD, McMasters KM. Factors associated with surgical options for
breast carcinoma. Cancer 2006; 106:1462-1466.
66. Li Y, Ellis SE, Ray M, Wo J, Martin RC. A Novel External Esophageal Perfusion Model for
Reflux Esophageal Injury. Digestive Diseases and Sciences, 51(3), 527-532, 2006.
67. Chagpar AB, Scoggins CR, Martin RC, Cook EF, McCurry T, Mizaguchi N, Paris KJ,
Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, McMasters, KM. Predicting patients at
low probability of requiring post-mastectomy radiation therapy”. Ann of Surg Onc,
2006:14:670-677.
68. Martin RCG, Husheck Steven, Scoggins CR, McMasters KM. Intraoperative Magnetic
Resonance Imaging Ablation of Hepatic Tumors. Surgical Endoscopy 2006; 20(10): 1536-
1542.
69. Martin RCG. Adjuvant Treatment of Stage II Colon Cancer: Is there a true no
chemotherapy group? Editorial Ann Surg Onc 13(6), 766-767, 2006.
70. D'Angelica M, Maddineni S, Fong Y, Martin RCG, Cohen MS, Ben-Porat L, Gonen M,
DeMatteo RP, Blumgart LH, Jarnagin WR. Optimal abdominal incision for partial
hepatectomy: increased late complications with Mercedes-type incisions compared to
extended right subcostal incisions. World J Surg 2006; 30:410-418.
71. Martin RCG. Hepatic Tumor Ablation: Cryo versus Radiofrequency, which is better?
Editorial Am Surg, 72(5) 391-392, 2006.
72. Lewis A, Martin RCG. The Treatment of Hepatic Metastases in Colorectal Carcinoma.
American Surgeon 2006; 72(6): 466-473.
CURRICULUM VITAE January 5th, 2014
28
73. Li Y, Wo J, Su R, Ray M, Martin RCG. Morphological Transformation in Esophageal
Submucosa by Bone Marrow Cells Esophageal Implantation under External Esophageal
Perfusion. Stem Cells and Development, Oct, 15 (5):697-705 2006.
74. Eid S, Stromberg AJ, Ames S, Ellis S, McMasters KM, Martin RCG. Assessment of
symptom experience in patients undergoing hepatic resection or ablation. Cancer, 107(11),
2715-2720, 2006.
75. Scoggins CR, Ross MI, Reintgen DS, Noyes, Goydos JS, Beitsch PD, Urist MM, Martin
RCG, Abrecht J, MaMasters KM Prospective multi-institutional study of reverse
transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol
2006; 24:2849-2857.
76. Scoggins CR, Ross MI, Reintgen DS, Noyes, Goydos JS, Beitsch PD, Urist MM, Martin
RCG, Abrecht J, McMasters KM Gender-related differences in outcome for melanoma
patients. Ann Surg 2006; 243:693-700.
77. Chagpar AB, Scoggins CR, Martin RC, McMasters KM. Prediction of sentinel lymph node-
only disease in women with invasive breast cancer. Am J Surg 2006; 192:882-887.
78. Martin RCG, Ahn J, Nowell S, Hein DW, Doll M, Martini B, Ambrosone CB. Association
between Manganese Superoxide Dismutase Promoter Gene Polymorphism and Breast Cancer
Survival. Breast Cancer Research; 8(4), R45- 2006.
79. Chagpar AB, McMasters KM, Martin RC, Scoggins CR. Determinants of early distant
metastatic disease in elderly patients with breast cancer. Am J Surg 2006; 192:317-321.
80. Wells G, Martin RC, McMasters KM, Scoggins CR. Soft tissue sarcoma of the extremity
and trunk: issues for the general surgeon. Am Surg 2006; 72:665-671.
81. Martin RCG. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in
the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus
Statement. Ann Surg Onc 14 (1) 128-133, 2007.
82. Martin RC, Eid S, Scoggins CR. Health-related quality of life: return to baseline after major
and minor liver resection. Surgery 2007; 142:676-684.
83. Li Y., Wo J., Su R, Ray M, Martin RCG. Loss of Manganese Superoxide Dismutase
Expression and Activity in Rat Esophagus with External Esophageal Perfusion. Surgery
141(3) 359-367, 2007.
84. Li Y., Wo J., Su R, Ray M, Martin RCG. Alterations in Manganese Superoxide Dismutase
CURRICULUM VITAE January 5th, 2014
29
expression in the progression from reflux esophagitis to esophageal adenocarcinoma. Ann
Surg Onc 14(7) 2045-2055, 2007.
85. Martin RCG, Scoggins CR, McMasters KM. Microwave Hepatic Ablation: Safety and
Efficacy. J Surg Oncol 2007; 96:481-486.
86. Martin RCG, Loehle J, Scoggins CR, McMasters KM. Kentucky Hepatoma:
epidemiological variant or same problem different region? Arch Surg 142(5), 431-436 2007.
87. Woodall CE, Scoggins CR, Loehle J, Ravindra KV, McMasters KM, Martin RCG. Hepatic
Imaging Characteristics Predict Overall Survival in Hepatocellular Carcinoma. Ann Surg
Onc 2007; 14(10):2824-2830.
88. Iannitti D., Martin RCG, Simon C, Newcomb W, McMasters KM, Dupuy, D. Hepatic
Tumor Ablation with Clustered Microwave Antennae: The US Phase II Trial. HPB 9(2); 120-
124, 2007.
89. Chagpar RB, Ross MI, Reintgen DS, Edwards MJ, Scoggins CR, Martin RC, Noyes RD,
Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, McMasters KM.
Factors associated with improved survival among young adult melanoma patients despite a
greater incidence of sentinel lymph node metastasis. J Surg Res 2007 Nov;143(1):164-168.
90. Chagpar AB, Scoggins CR, Martin RC, McMasters KM. Predicting patients at low
probability of requiring postmastectomy radiation therapy. Ann Surg Oncol 2007; 14:670-
677.
91. Weber R, Jabboru N, Martin RCG. Anemia and Transfusions in Patients Undergoing
Surgery for Cancer. Ann Surg Onc 2008; 15(1):34-45.
92. Chagpar AB, Scoggins CR, Martin RC, Carlson DJ, Laidlely AL, Eid SE, McGlothin TQ,
McMasters KM. Are 3 sentinel nodes sufficient? Arch Surg 2007 May;142(5):456-9;
discussion 459-60.
93. Pawlik TM, Gleisner AL, Bauer TW, Adams RB, Reddy SK, Clary BM, Martin RCG,
Scoggins CR, Tanabe KK, Michaelson JS, Kooby DA, Staley CA, Schulick RD, Vauthey JN,
Abdalla EK, Curley SA, Choti MA, Elias D. Liver-Directed Surgery for Metastatic
Squamous Cell Carcinoma to the Liver: Results of a Multi-Center Analysis. Ann Surg Onc
June 2007; 14(10):2807-2816.
94. Helm CW, Toler CR, Martin RCG, Gordinier ME, Parker LP, Metzinger DS, Edwards RP.
Cytoreduction and Intraperitoneal Heated Chemotherapy (IPHC) for the Treatment of
Endometrial Carcinoma Recurrent Within the Peritoneal Cavity. Int J. Gynecol Cancer 2007;
CURRICULUM VITAE January 5th, 2014
30
17(1):204-209.
95. Helm CW, Randall-Whitis L, Martin RCG, Metzinger D, Gordinier M, Parker L, Edwards
R. Hyperthermic Intraperitoneal Chemotherapy In Conjunction With Surgery For The
Treatment Of Recurrent Ovarian Carcinoma. Gynecologic Oncology 2007; 105(1):90-96.
96. Li Y, Martin RCG. Reflux injury of esophageal mucosa: experimental studies in animal
models of esophagitis, Barrett’s esophagus and esophageal adenocarcinoma. Dis of
Esophagus 2007; 20(5):372-378
97. Martin RCG Invited commentary for Lancet Oncology 2007 of manuscript: Camacho et al
The Lancet Oncology: http://oncology.thelancet.com
98. Martin RCG, Liu Q, Wo JM, Ray MB, Li Y. Chemoprevention of Carcinogenic Progression
to Esophageal Adenocarcinoma by the Manganese Superoxide Dismutase Supplementation.
Clinical Cancer Research 2007;13(17):5176-5182.
99. Chagpar AB, Scoggins CR, Martin RC, Sahoo S, Carlson DJ, Laidley AL, El-Eid SE,
McMasters KM. Factors determining adequacy of axillary node dissection in breast cancer
patients. Breast J 2007; 13:233-237.
100. Chagpar AB, McMasters KM, Saul J, Nurko J, Martin RC, Scoggins CR, Edwards MJ. Body
mass index influences palpability but not stage of breast cancer at diagnosis. Am Surg. 2007
Jun;73(6):555-60.
101. Woodall CE, Scoggins CR, Lewis AM, McMasters KM, Martin RCG. Hepatic Malignant
Epithelioid Hemangioendothelioma: A case report and review of the literature. Am Surg
2008; 74(1):64-68.
102. Woodall CE, Scoggins CR, Lewis AM, McMasters KM, Martin RCG. Adequate
Lymphadenectomy Results in Accurate Nodal Staging without an Increase in Morbidity in
Patients with Gastric Adenocarcinoma. Am J Surg 2008; 196(3) 413-17.
103. Chagpar AB, McMasters KM, Scoggins CR, Martin RC, Thoene C, Edwards MJ. The use
of radiation therapy after breast-conserving surgery in hormonally treated breast cancer
patients is dependent on patient age, geographic region, and surgeon specialty. Am J Surg
2008 June; 195(6):793-8.
104. Federico AC, Chagpar AB, Ross MI, Martin RC, Noyes RD, Goydos JS, Beitsch PD, Urist
MM, Ariyan S, Sussman JJ, McMasters KM, Scoggins CR. Effect of Multiple-Nodal Basin
Drainage on Cutaneous Melanoma. Arch Surg 2008 July;143(7):632-7.
CURRICULUM VITAE January 5th, 2014
31
105. Landry CS, Scoggins CR, McMasters KM, Martin RCG. Management of Hepatic
Metastasis of Gastrointestinal Carcinoid Tumors. J Surg Oncol 2008; 97(3): 253-258.
106. Li Y, Woodall CE, Wo JM, Zheng H, Ng CK, Ray MB, Martin RCG. The use of dynamic
positron emission tomography imaging for the evaluation of the carcinogenic progression of
intestinal metaplasia to esophageal adenocarcinoma. Cancer Invest 2008 26(3): 278-285.
107. Landry CS, McMasters KM, Scoggins CR, Martin RCG. Proposed Staging System for
Gastrointestinal Carcinoid Tumors. Am Surg 2008 74(5): 418-422.
108. Martin RCG, Barker DF, Doll MA, Pine S, Mechanic L, Bowman ED, Harris CC, Hein
DW. Manganese Superoxide Dismutase Gene Coding Region Polymorphisms Lack Clinical
Incidence in General Population. DNA and Cell Biol. 2008 27(6): 321-323.
109. Landry CS, McMasters KM, Scoggins CR, Woodall CE, Martin RCG. Analysis of 900
Appendiceal Carcinoid Tumors with a Proposal for a Staging System. Arch Surg 2008
143(7): 664-670. G19
110. Martin RCG, Duvall R, Ellis SE, Scoggins CR. The Use of Self-Expanding Silicone Stents
in Esophageal Strictures: Less Cost and More Efficiency. Ann Thor Surg 2008, 86(2) 436-
440.
111. Woodall CE, Scoggins CR, Martin RCG. Yttrium-90 use in unresectable primary and
metastatic liver tumors. US Gastroenterology Review, June 2008.
112. Kooby DA, Gillespie T, Bentrem D, Nakeeb A, Schmidt CM, Merchant N, Parikh A, Martin
RCG; Scoggins C, Ahmad S, Kim HJ, Park J, Johnston F, Strouch M, Menze A, Rymer J;
McClaine R, Strasberg S, Talamonti M, Staley C, McMasters K, Lowy A, Byrd-Sellers J,
Wood W, Hawkins W. Left-sided pancreatectomy: a multicenter analysis of open and
laparoscopic approaches. Annals of Surgery 2008; 248(3):438-446.
113. Deneve J, Pawlik T, Cunningham S, Clary B, Reddy S, Scoggins C, Martin RCG, D'Angelica
M, Staley C, Choti M, Jarnagin, W, Schulick R, Kooby DA. Liver cell adenoma: a
multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2008.
114. Landry CS, Brock, G, McMasters KM, Scoggins CR, Martin RCG. A Proposed Staging
System for Small Bowel Carcinoid Tumors Based on an analysis of 6,380 patients. Am J
Surg 196(6) 896-903, 2008.
115. Landry CS, McMasters KM, Scoggins CR, Martin RCG A proposed Staging System for
Gastric Carcinoid Tumors Based on an Analysis of 1,543 Patients. Ann Surg Onc 16(1), 51-
60, 2009.
CURRICULUM VITAE January 5th, 2014
32
116. Landry CS, Brock G, McMasters KM, Scoggins CR, Martin RCG. A Proposed Staging
System for Rectal Carcinoid Tumors based on an Analysis of 4701 patients. Surgery 144(3)
460-466, 2008.
117. Reuter NP, MacGregor JM, Woodall CE, Sticca RP, Helm CW, Scoggins CR, McMasters
KM, Martin RCG. Preoperative performance status predicts outcomes following
hyperthermic intraperitoneal chemotherapy. Am J Surg 2008 December Vol 196(6): 909-14.
118. Landry CS, Brock G, Scoggins CR, McMasters KM, Martin RCG. Proposed Staging
System for Colon Carcinoid Tumors Based on an Analysis of 2,459 Patients. J Am Coll
Surg. 207(6) Dec 2008:874-881.
119. Woodall CE, Duvall R, Scoggins CR, McMasters KM, Martin RCG. Esophageal carcinoma
histology affects peri-operative morbidity following open esophagogastrectomy. J Onc 2008:
1-7
120. Martin RC, Barker DF, Doll MA, Oine SR, Mechanic L, Bowman ED, Haris CC, Hein DW.
Manganese superoxide dismutase gene coding region polymorphisms lack clinical incidence
in general population. DNA Cell Biol 2008; 27(6):321-323.
121. Martin RCG, Scoggins CR, Egnatashvili V, Staley C, McMasters KM, Kooby DA. Arterial
and Venous Resection for Pancreatic Adenocarcinoma: Operative and Long-term Outcomes.
Arch Surg 2009; 2:154-159.
122. Martin RCG, Li Y, Liu Q, Jensen NS, Barker DF, Doll MA, Hein DW. Manganese
Superoxide Dismutase V16A Single Nucleotide Polymorphism in the Mitochondrial
Targeting Sequence is Associated with Reduced Enzymatic Activity in Cryopreserved
Human Hepatocytes. DNA Cell Biol, 28(1), 3-7, 2009.
123. Shelgikar CS, Loehle J, Scoggins CR, McMasters KM, Martin RCG. Empiric Antibiotics
for Transarterial Embolization in Hepatocellular Carcinoma: Indicated? J Surg Res 151(1);
121-124: 2009
124. Martin RCG, Duvall R, Ellis SE, Scoggins CR. The Use of Self-Expanding Silicone Stents
in Esophageal Cancer Care: Optimal Pre-, Peri-, and Post-operative Care. Surgical
Endoscopy 2009, 23 (3):615-620.
125. Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RCG. Radiofrequency
ablation versus resection for hepatic colorectal metastasis therapeutically equivalent? J GI
Surg 2009 Mar: 13(3): 486-91.
CURRICULUM VITAE January 5th, 2014
33
126. Merchant NB, Rymer J, Koehler EA, Ayers GD, Castellanos J, Kooby DA, Weber SH, Cho
CS, Schmidt CM, Nakeeb A, Matos JM, Scoggins CR, Martin RC, Kim HJ, Ahmad SA,
Chu CK, McCaine R. Bednarski BK, Staley CA, Sharp K, Parikh AA. Adjuvant
Chemoradiation Therapy for Pancreatic Adenocarcinoma: Who Really Benefits? Surg 2009
May; 208(5):829-38.
127. Weber SM, Cho CS, Merchant N, Pinchot S. Rettammel R, Nakeeb A, Bentrem D, Parikh A,
Mazo AE, Martin RC, Scoggins CR, Ahmad SA, Kim HJ, Hamilton N, Hawkins W, Max
Schmidt C, Kooby DA. Laparoscopic left pancreatectomy: complication risk score
correlates with morbidity and risk for pancreatic fistula. Ann Surg Oncol 2009
Oct;16(10):2825-33.
128. Byam J, Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RCG. Should
hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver
resection/ablation? Ann Surg Oncol 2009 Nov 3:7:80
129. Li Y, Wo J, Liu Q, Li X, Martin RCG. Chemoprotective Effects of Curcuma Aromatica on
Esophageal Carcinogenesis. Ann Surg Onc 2009; 2:515-523.
130. Scoggins CR, Campbell ML, Landry CS, Slomiany BA, Woodall CE, McMasters KM,
Martin RCG. Preoperative Chemotherapy Does Not Increase Morbidity or Mortality of
Hepatic Resection for Colorectal Cancer Metastases. Ann Surg Onc 16(1), 35-41, 2009
131. Woodall CE, Scoggins CR, Ravindra K, Ellis SF, Tatum CM, Hahl MJ, Hiken JN, Jones BC,
McMasters KM, Martin RCG. Is Selective Internal Radioembolization Safe and Effective
for Patients with Inoperable Hepatocellular Carcinoma and Venous Thrombosis? J Am Coll
Surg 2009 Mar; 208(3): 375-382
132. Martin RCG, Augenstein V, Reuter NR, Scoggins CR, McMasters KM. Simultaneous vs.
Staged Resection for Synchronous Colorectal Cancer Liver Metastases. J Am Coll Surg 2009
May; 208(5):842-850
133. Bower M, Jones W, Vessels B, Scoggins CR, Martin RCG. Nutritional Support with
Endoluminal Stenting during Neoadjuvant Therapy for Esophageal Malignancy. Ann Surg
Oncol 2009; 16:31661-3168.
134. Woodall CW, Li Y, Liu Q, Reuter N, Martin RCG. Chemoprevention of metaplasia
initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol
supplementation. Anticancer Drugs 20 (6): 437-443 2009.
135. Woodall CE, Brock GN, Fan J, Byam JA, Scoggins CR, McMasters KM, Martin RCG. An
Evaluation of 2,537 Gastrointestinal Stromal Tumors for a Proposed Clinical Staging
CURRICULUM VITAE January 5th, 2014
34
System. Arch Surg 144(7): 670-678, 2009
136. Woodall CE, Martin RC, Stromberg AJ, Ginter B, Burton A, Ross MI, Edwards MJ,
McMasters KM, Scoggins CR. Do melanoma patients from southern climates have a worse
outcome than those form northern climates? Am Surg 2009 Aug; 75(8):687-92; discussion
692.
137. Reuter NP, Martin RCG. Microwave energy as a pre-coagulative device to assist in hepatic
resection. Ann Surg Onc 16: 3057-3063, 2009
138. Bower M, Martin RCG. Nutritional Management during Neoadjuvant Therapy for
Esophageal Cancer. J Surg Onc 2009 July Vol 100(1): 82-87
139. Martin RCG, Robbins K, Tomalty D, O’Hara R, Bosnjakovik Padr R, P, Derner M, Rocek
M, Slauf F, Scupchenko A, and Tatum C. Transarterial chemoembolization (TACE) using
irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients
with colorectal cancer: An Interim Report. World J of Surg Onc 2009, 7:80:1-12.
140. Jones, WF, Martin RCG. Confronting the barriers to colorectal cancer screening and
treatment. J KY Med Assoc, 107(3): 86-87, 2009
141. Martin RCG, Joshi J, Robbins K, Tomalty D, O’Hara R. Tatum C. Transarterial
Chemoembolization of Metastatic Colorectal Carcinoma with Drug Eluting Beads: Multi-
Institutional Study. J of Oncology 12(5), 539-545, 2009
142. Schiffman SC, Woodall CE, Kooby DA, Martin RC, Staley CA, Egnatashvili V, McMasters
KM, Scoggins CR. Factors associated with recurrence following hepatectomy for large
hepatocellular carcinoma: A multicenter analysis. J Surg Oncol 2009; 101(2);105-11.
143. Martin RC, Scoggins CR, McMasters KM. Safety and Efficacy of microwave ablation of
hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 2010
Jan;17(1):171-8
144. Li Y, Reuter NP, Li X, Liu Q, Zhang J, Martin RCG. Colocalization of MnSOD expression
in response to oxidative stress. Mol Carcinog 2010 Jan;49(1):44-53
145. Scoggins CR, Martin RC, Ross MI, Edwards MJ, Reintgen DS, Urist MM, Gershenwald JE,
Sussman JJ, Beitsch PD, McMasters KM. Factors Associated with False-Negative Sentinel
Lymph Node Biopsy in Melanoma Patients. Ann Surg Oncol 2010 17:709-717.
146. Whitney R, Tatum C, Hahl M, Ellis S, Scoggins CR, McMasters KM, Martin RCG. Safety
of Hepatic Resection in metastatic disease to the liver after Yttrium-90 therapy. J Surg Res
CURRICULUM VITAE January 5th, 2014
35
Available online 12 June 2009.
147. Martin RCG, Li Y, Liu Q, Barker DF, Doll MA, Hein DW. MnSOD genotype and the
expression effects on Lung Cancer Initiation and Biology. Cancer Investigation 1-7, 2009
ISSN: 0735-7907 print / 1532-4192 online
148. Carter S, Martin RCG. Drug Eluting Bead Therapy in Primary and Metastatic Disease to
the Liver. HPB 11(7), 541-550, 2009
149. Benns M, Woodall C, Scoggins CR, McMasters KM, Martin RCG. The Impact of Obesity
on Outcomes Following Pancreatectomy for Malignancy. Ann Surg Onc 16((), 2565-2569,
2009.
150. Bower MR, Metzger T, Robbins K, Tomalty D, Andrasina T, Tatum C, Scoggins CR,
McMasters KM, Martin RCG. Surgical Downstaging and Neo-adjuvant therapy in
metastatic colorectal carcinoma with irinotecan drug eluting beads: a multi-institutional
study. HPB 12(1); 31-36, 2010.
151. Martin RCG, McMasters KM, Scoggins CR. Laparoscopic Hepatic Lobectomy: Advantages
Of A Minimally Invasive Approach. JACS 210(5) 627-631, 2010.
152. Bower MR, Aiyer HA, Martin RCG. Chemoprotective Effects of Curcumin in Esophageal
Epithelial Cells Exposed to Bile Acids. WJ Gastroenterology 16(33): 4151-4158, 2010.
153. V. J. Picozzi; R. A. Abrams; P. A. Decker; W. Traverso; E. M. O'Reilly; E. Greeno; R.C.
Martin; L. S. Wilfong; M. L. Rothenberg; M. C. Posner; P. W. T. Pisters; for the American
College of Surgeons Oncology Group. Multicenter phase II trial of adjuvant therapy for
resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based
chemoradiation: ACOSOG Trial Z05031. Annals of Oncology 2010; doi: 10.1093/annonc
154. Brown R, Bower M, Martin RCG. Hepatic Resection for Colorectal Liver Metastases
Surgical Clinics of North America (SCNA) Liver Surgery, 90(4): 839-852, 2010.
155. Bower M, Jones W, Vessels B, Scoggins CR, Martin RCG. The role of esophageal stents in
the nutritional support of patients with esophageal malignancy. Nutrition in Clinical Practice
June 2010 Vol 25(3); 244-249
156. Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM,
Stromberg AJ, McMasters KM, Scoggins CRl. Should all patients with melanoma between 1
and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer 2010 Mar 15,
116(6) pp 1535-44.
CURRICULUM VITAE January 5th, 2014
36
157. Schiffman SC, Chu CK, Park J, Russell M, Keilin S, Kooby DA, Scoggins CR, McMasters
KM, Martin RCG. Is prior cholecystectomy associated with decreased survival in patients
with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy? Am J Surg
Available online Sept 28
158. Augenstein VA, Reuter NP, Bower MR, McMasters KM, Scoggins CR, Martin RCG.
Routine intra-operative biliary cultures during pancreaticoduodenectomy: A guide to avoid
postoperative complications. J Surg Onc 2010 Oct 1; 102(5); 478-81.
159. Martin RCG, Howard J, Tomalty D, Robbins K, Padr R, Bosnjakovic PM, Tatum C.
Toxicity of Irinotecan Eluting Beads in the treatment of Hepatic Malignancies: Results of
Multi-Institutional Registry. CVIR 2010; 33(5) 960-66.
160. Bowling, J. T.; Reuter, N. P.; Martin, R. C.G.; McMasters, K. M.; Tatum, C.; Scoggins, C.
R. Prior Biliary Tree Instrumentation Does Not Preclude Hepatic Arterial Therapy for
Malignancy. Am. Surg 2010; 76, 618-621.
161. Brown R, Hagendoorn L, Stromberg AJ, Scoggins CR, McMasters KM, Martin RCG.
Surveillance after Surgical Treatment of Melanoma: Futility of Routine Chest Radiography.
Surgery 2010 Vol 148(4) 711-717.
162. Schiffman SC, Li Y, Dryden GW, Li X, Martin RCG. Image analysis by mini-endoscopy in
rats after esophagoduodenal anastomosis. Surg Endo 24 (11) 2835-2841, 2010.
CURRICULUM VITAE January 5th, 2014
37
163. Schiffman SC, Li Y, Li X, Aiyer HA, Martin RCG. The Resistance if Esophageal
Cancer Cells to Bile Salt Insult Is Associated with Manganese Superoxide Dismutase. J
Surg Res 2010. Vol 158(2) Feb 2010, page 2.
164. Aiyer HS, Li Y, Losso JN, Gao C, Schiffman SC, Slone SP, and Martin RC: Effect of
freeze-dried berries on the development of reflux-induced esophageal adenocarcinoma.
Nutr Cancer 2011, 63:1256-1262
165. Aiyer HS, Li Y, Harper N, Myers SR, and Martin RC: Molecular changes in the
esophageal epithelium after a subchronic exposure to cigarette smoke in the presence of
bile-acid reflux. Inhal Toxicol 2011, 23:304-311
166. Aiyer HS, Li Y, Liu QH, Reuter N, and Martin RC: Dietary freeze-dried black
raspberry's effect on cellular antioxidant status during reflux-induced esophagitis in rats.
Nutrition 2011, 27:182-187.
167. Aiyer, HS, Li Y, and Martin RC: Diet composition affects surgery-associated weight
loss in rats with a compromised alimentary tract. J Surg Res 2011, 168:42-48
168. Bower M, Sherwood L, Li Y, and Martin R: Irreversible electroporation of the pancreas:
definitive local therapy without systemic effects. J Surg Oncol 2011, 104:22-28
169. Bower M, Ellis SF, Scoggins CR, McMasters KM, and Martin RC: Phase II comparison
study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol
2011, 18:166-173
170. Brown RE, St Hill CR, Greene QJ, Farmer RW, Reuter NP, Callendar GG, Martin RC,
McMasters KM, and Scoggins CR: Impact of histology on survival in retroperitoneal
sarcomas. Am J Surg 2011, 202:748-752
171. Brown RE, Abbas AE, Ellis S, Williams S, Scoggins CR, McMasters KM, and Martin RC:
A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for
esophageal cancer: optimal performance and surgical safety. J Am Coll Surg 2011, 212:582-
588
172. Brown RE, Gibler KM, Metzger T, Trofimov I, Krebs H, Romero FD, Scoggins CR,
McMasters KM, and Martin RC: Imaged guided transarterial chemoembolization with drug-
eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma:
early outcomes from a multi-institutional registry. Am Surg 2011, 77:93-98
173. Brown RE, Martin RC, and Scoggins CR: Ablative therapies for colorectal liver
metastases. Surg Oncol Clin N Am 2011, 20:259-71, vii
CURRICULUM VITAE January 5th, 2014
38
174. Brown RE, Bower MR, Metzger TL, Scoggins CR, McMasters KM, Hahl MJ, Tatum C,
and Martin RC: Hepatectomy after hepatic arterial therapy with either yttrium-90 or
drug-eluting bead chemotherapy: is it safe? HPB (Oxford) 2011, 13:91-95
175. Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC,
McMasters KM, Scoggins CR, and Callender GG: Regression does not predict nodal
metastasis or survival in patients with cutaneous melanoma. Am Surg 2011, 77:1009-
1013
176. Burton AL, Roach BA, Mays MP, Chen AF, Ginter BA, Vierling AM, Scoggins CR,
Martin RC, Stromberg AJ, Hagendoorn L, and McMasters KM: Prognostic significance
of tumor infiltrating lymphocytes in melanoma. Am Surg 2011, 77:188-192
177. Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ,
Hagendoorn L, Martin RC, and McMasters KM: Prognostic implications of anatomic
location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg 2011, 202:659-
664
178. Cannon RM, Martin RC, Callender GG, McMasters KM, and Scoggins CR: Safety and
efficacy of hepatectomy for colorectal metastases in the elderly. J Surg Oncol 2011,
104:804-808
179. Chagpar RB, Martin RC, Ahmad SA, Kim HJ, Rupp C, Weber S, Ebelhar A, Gilbert J,
Brinkman A, Winslow E, Cho CS, Kooby D, Chu CK, Staley CA, McMasters KM, and
Scoggins CR: Medically managed hypercholesterolemia and insulin-dependent diabetes
mellitus preoperatively predicts poor survival after surgery for pancreatic cancer. J
Gastrointest Surg 2011, 15:551-557.
180. Cho CS, Kooby DA, Schmidt CM, Nakeeb A, Bentrem DJ, Merchant NB, Parikh AA,
Martin RC, Scoggins CR, Ahmad SA, Kim HJ, Hamilton N, Hawkins WG, and Weber
SM: Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the
safer technique? Ann Surg 2011, 253:975-980
181. Egger ME, Gilbert JE, Burton AL, McMasters KM, Callender GG, Quillo AR, Brown
RE, St Hill CR, Hagendoorn L, Martin RC, Stromberg AJ, and Scoggins CR:
Lymphovascular invasion as a prognostic factor in melanoma. Am Surg 2011, 77:992-
997
182. Farmer RW, , Kralj I, Valdata A, Urbano J, Enguix DP, Monaco RG, Scoggins CR,
McMasters KM, Rustein L, and Martin RC: Hepatic arterial therapy as a bridge to
ablation or transplant in the treatment of hepatocellular carcinoma. Am Surg 2011,
CURRICULUM VITAE January 5th, 2014
39
77:868-873
183. Li Y, Martin RC: Herbal medicine and hepatocellular carcinoma: applications and
challenges. Evid Based Complement Alternat Med 2011:541209
184. Li Y, Reuter N, Li XS, Martin RCG. Manganese superoxide dismutase
chemoprevention in a murine hepatitis associated injury model. Journal of Cancer
Therapy 2011;2:431-440.
185. Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC, McMasters
KM, Cho CS, Winslow ER, Wood WC, and Staley CA, III: Importance of low
preoperative platelet counts in selecting patients for resection of hepatocellular
carcinoma: a multi-institutional analysis. J Am Coll Surg 2011, 212:638-648
186. Martin RC, Brown R, Puffer L, Block S, Callender G, Quillo A, Scoggins CR, and
McMasters KM: Readmission rates after abdominal surgery: the role of surgeon, primary
caregiver, home health, and subacute rehab. Ann Surg 2011, 254:591-597
187. Martin RC, Rustein L, Perez ED, Palmero J, Carvalheiro V, Urbano J, Valdata A, Kralj
I, Bosnjakovic P, and Tatum C: Hepatic arterial infusion of doxorubicin-loaded
microsphere for treatment of hepatocellular cancer: a multi-institutional registry. J Am
Coll Surg 2011, 213:493-500
188. Martin RC, Kooby DA, Weber SM, Merchant NB, Parikh AA, Cho CS, Ahmad SA,
Kim HJ, Hawkins W, and Scoggins CR: Analysis of 6,747 pancreatic neuroendocrine
tumors for a proposed staging system. J Gastrointest Surg 2011, 15:175-183 2011 Best J
of GI Surg Paper Award Winner
189. Martin RC, Joshi J, Robbins K, Tomalty D, Bosnjakovik P, Derner M, Padr R, Rocek
M, Scupchenko A, and Tatum C: Hepatic intra-arterial injection of drug-eluting bead,
irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic
chemotherapy: results of multi-institutional study. Ann Surg Oncol 2011, 18:192-198
190. Picozzi VJ Abrams RA, Decker PA, Traverso W, O'Reilly EM, Greeno E, Martin RC,
Wilfong LS, Rothenberg ML, Posner MC, and Pisters PW: Multicenter phase II trial of
adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and
interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol 2011,
22:348-354
191. Ramsey AM and Martin RC: Body mass index and outcomes from pancreatic resection:
a review and meta-analysis. J Gastrointest Surg 2011, 15:1633-1642
CURRICULUM VITAE January 5th, 2014
40
192. Schiffman SC, Li Y, Xiao D, Li X, Aiyer HS, and Martin RC: The resistance of
esophageal adenocarcinoma to bile salt insult is associated with manganese superoxide
dismutase expression. J Surg Res 2011, 171:623-630
193. Schiffman SC, McMasters KM, Scoggins CR, Martin RC, and Chagpar AB: Lymph
node ratio: a proposed refinement of current axillary staging in breast cancer patients. J
Am Coll Surg 2011, 213:45-52
194. Schiffman SC, Chu CK, Park J, Russell M, Keilin S, Kooby DA, Scoggins CR,
McMasters KM, and Martin RC: Is prior cholecystectomy associated with decreased
survival in patients with resectable pancreatic adenocarcinoma following
pancreaticoduodenectomy? Am J Surg 2011, 201:519-524
195. Schiffman SC, Metzger T, Dubel G, Andrasina T, Kralj I, Tatum C, McMasters KM,
Scoggins CR, and Martin RC: Precision hepatic arterial irinotecan therapy in the
treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and
prolonged overall survival. Ann Surg Oncol 2011, 18:431-438
196. Whitney R, Valek V, Fages JF, Garcia A, Narayanan G, Tatum C, Hahl M, and Martin
RC: Transarterial chemoembolization and selective internal radiation for the treatment of
patients with metastatic neuroendocrine tumors: a comparison of efficacy and cost.
Oncologist 2011, 16:594-601
197. Whitney R, , Tatum C, Hahl M, Ellis S, Scoggins CR, McMasters K, and Martin RC:
Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J
Surg Res 2011, 166:236-240
198. Cannon RM, , Legrand R, Chagpar RB, Ahmad SA, McClaine R, Kim HJ, Rupp C, Cho
CS, Brinkman A, Weber S, Winslow ER, Kooby DA, Chu CK, Staley CA, Glenn I,
Hawkins WG, Parikh AA, Merchant NB, McMasters KM, Martin RC, Callender GG,
Scoggins CR. Multi-institutional analysis of pancreatic adenocarcinoma demonstrating
the effect of diabetes status on survival after resection. HPB (Oxford). 2012
Apr;14(4):228-35.
199. Callender GG, Gershenwald JE, Egger ME, Scoggins CR, Martin RC 2nd, Schacherer
CW, Edwards MJ, Urist MM, Ross MI, Stromberg AJ, McMasters KM. A Novel and
Accurate Computer Model of Melanoma Prognosis for Patients Staged by Sentinel
Lymph Node Biopsy: Comparison with the American Joint Committee on Cancer Model.
J Am Coll Surg. 2012 Feb 16. Vol 214(4):608-17
200. Schiffman SC, Li Y, Martin RC. The Association of Manganese Superoxide Dismutase
Expression in Barrett's Esophageal Progression with MnTBAP and Curcumin Oil
CURRICULUM VITAE January 5th, 2014
41
Therapy. J Surg Res. 2011 Dec 13Vol 176(2): 535-541
201. Mbah NA, Brown RE, Bower MR, Scoggins CR, McMasters KM, Martin RC.
Differences between bipolar compression and ultrasonic devices for parenchymal
transection during laparoscopic liver resection. HPB (Oxford). 2012 Feb;14(2):126-31
202. Martin RC, Robbins K, Fagés JF, Romero FD, Rustein L, Tomalty D, Monaco R.
Optimal outcomes for liver-dominant metastatic breast cancer with transarterial
chemoembolization with drug-eluting beads loaded with doxorubicin. Breast Cancer
Res Treat. 2012 Apr;132(2):753-6363
203. Dunki-Jacobs EM, Martin R. Endoscopic Therapy for Barrett's Esophagus: A Review
of Its Emerging Role in Optimal Diagnosis and Endoluminal Therapy. Ann Surg Oncol.
2012 Vol 19(5): 1575-92
204. Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ,
Hagendoorn L, Martin RC 2nd, McMasters KM. Prognostic implications of
anatomiclocation of primary cutaneous melanoma of 1 mm or thicker. Am J Surg. 2011
Dec;202(6):659-64; discussion 664-5.
205. Harper N, Li Y, Farmer R, Martin RC. Epidermal Growth Factor Expression in
Esophageal Adenocarcinoma: A Clinically Relevant Target? J Gastrointest Surg. 2012
Vol 16:946-955
206. Martin RCG, Geller DA, Espat JN, Kooby DA, Sellars M, Goldstein RG, Imagawa DK,
Ulrich F, Scoggins CR. Safety and Efficacy of Trans Arterial ChemoEmbolization with
Drug-Eluting Beads in Hepatocellular Cancer: An Optimal Therapy.
Hepatogastroenterology 2012; Vol 59(113): 255-260.
207. Li Y, Reuter NP, Liu Q, Li X, Martin RCG. Manganese Superoxide Dismutase
Chemoprevention in a Murine Hepatitis Associated Injury Model. J of Cancer Therapy
2011; Vol 2(3): 431-440
208. Joshi J, Robbins K, Valek V, Andrasina T, Boudny J, Padr R, O’Hara R, Tomalty D,
Martin RCG. Hepatic Arterial Infusion – Doxorubicin Loaded Microsphere for the
Treatment of Metastatic Breast Cancer to the Liver: Results from a Multi-Institutional
Registry. Interven Oncology 2010.
209. Brown RE, Abbas AE, Ellis SF, White S, Scoggins CR, McMasters KM, Martin RCG.
A Prospective Phase II Evaluation of Esophageal Stenting for Neoadjuvant Therapy for
Esophageal Cancer: Optimal Performance and Surgical Safety. J Am Col Surg 2011; Vol
212(4): 582-88.
CURRICULUM VITAE January 5th, 2014
42
210. Whitney R, Valek V, Fages JF, Garcia A, Narayanan G, Tatum C, Hahl, M, Martin RCG.
Transarterial Chemoembolization and Selective Internal Radiation for the Treatment of
Patients with Metastatic Neuroendocrine Tumors: A Comparison of Efficacy and Cost.
The Oncologist 2011; Vol 16(5): 594-601.
211. Martin RCG, Irurzun I, Munchart J, Trofimov I, Scupchenko A, Tatum C, Narayanan G.
Optimal Technique of Doxorubicin Beads in Hepatocellular Cancer: beads size, dose, and
response. Korean J Hepatol 2011. Vol 17; 51-60.
212. Farmer R, , Kralj I, Valdata A, Urbano J, Pérez Enguix D, Monaco R, Scoggins CR,
McMaster KM, Rustein L, Martin RCG. Hepatic Arterial Therapy as a Bridge to
Ablation or Transplant in the Treatment of Hepatocellular Carcinoma. Am Surg 2011;
Vol 77(7): 868-873.
213. Ramsey A, Martin RCG. Body Mass Index and Outcomes Following Pancreatectomy:
A Meta Analysis. J or GI Surg 2011; Vol 15: 1633-1642.
214. Aiyer HS, Li Y, Harper N, Myers SR, Martin RCG. Molecular changes in the
esophageal epithelium after subchronic exposure to cigarette smoke in the presence of
bile-acid reflux. Inhalational Toxicol 2011. Vol 23(5): 304-311.
215. Schiffman S, Reuter NP, McMaster KM, Scoggins CR, Martin RCG. Overall Survival
of Peri-Hilar Cholangiocarcinoma Compared to Primary Endoscopic Therapy. J Surg
Onc 2010; Vol 105(1): 304-11.
216. Martin RCG, Rustein L, Enguix DP, Palmero J, Carvalheiro V, Urbano J, Valdata A,
Kralj I, Bosnjakovic P, Tatum C. Hepatic Arterial Infusion of Doxorubicin Loaded
Microsphere for Treatment of Hepatocellular Cancer: a Multi-Institutional Registry.
JACS 2011; Vol 213(4): 493-500.
217. Martin RCG, Brown R, Puffer L, Block S, Scoggins CR, McMaster KM. Readmission
Rates after Abdominal Surgery: The Role of Surgeon, Primary Caregiver, Home Health,
and Sub-acute Rehab. Ann Surg 2011; Vol 254(4): 591-95.
218. Martin RCG, Aiyer HS, Malik D, Li Y. Effect on Pro-inflammatory and Antioxidant
Genes and Bioavailable Distribution of Whole Tumeric vs Curcumin: Similar Root but
Different Effects. Food and Chemical Toxicology 2011; Vol 50(2); 227-31.
219. Dunki-Jacobs E, Martin RCG. Endoscopic Therapy for Barrett’s Esophagus: A Review
of its Emerging Role in Optimal Diagnosis and Endoluminal Therapy. Ann Surg Onc
2011; Vol 19(5): 1575-82.
CURRICULUM VITAE January 5th, 2014
43
220. Cannon RM, Rustein L, Enguix DP, Palmero J, Carvalheiro V, Urbano J, Valdata A,
Kralj I, Bosnjakovic P, Tatum C, Martin RCG. Management of Diffuse Hepatocellular
Cancer (≥ 10 Lesions) with Doxorubicin Loaded DC Bead is Safe and Effective
Treatment Option. Onkologie 2012; Vol 35: 184-188.
221. Mbah N, Brown RE, St Hill CR, Bower MR, Ellis SE, Scoggins CR, McMasters KM,
Martin RCG. Impact of Post-Operative Complications on Quality of Life after
Pancreaticoduodenectomy. J of Pancreas 2012: Vol 13(4): 387-393.
222. Fox M, Farmer R, Scoggins CR, McMasters KM, Martin RCG. Lymph Node Ratio is a
Significant Predictor of Disease Specific Mortality in Patients Undergoing
Esophagectomy for Cancer. Am Surg 2012; Vol 78(5): 528-34..
223. Kotoyan R, Lindeman T, Tatum C, Robbins K, Martin RCG. Hepatic Arterial Therapy
with Drug-eluting Beads in the management of Metastatic Pancreatic Carcinoma to the
Liver: a Multi-Institutional Registry. J of Oncology 2012: Article ID 168303: 1-6.
224. Lencioni R, Martin RCG, Geshwind J. Transcather treatment of HCC with DC Bead
Doxorubicin (DEBDOX) Technical Recommendations. CVIR 2012 Vol 35: 980-985
225. Schiffman SC, Li Y, Diao X, Li X, Aiyer HA, Martin RCG. The Association of
Manganese Superoxide Dismutase Expression in Barrett’s Esophageal Progression with
MnTBAP and Curcumin Oil Therapy. J Surg Res; Vol 176(2):535-41.
226. Fouad H, Metzger T, Tatum C, Robbins K, Martin RCG. Hepatic arterial therapy with
drug eluting beads in the management of metastatic bronchogenic carcinoma to the liver:
a multi-institutional registry. J of Oncology 2012; Article ID 292131: 1-6.
227. Martin RCG, Robbins K, Fagés JF, Romero FD, Rustein L, Tomalty D, Monaco R.
Optimal Outcomes for Liver Dominant Metastatic Breast Cancer with Transarterial
Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin. Br C Res Tre
2012; Vol 132(2): 753-63.
228. Martin RCG, Scoggins CR, Tomalty D, Schreeder M, Metzger T, Tatum C, Sharma V.
Irinotecan Drug-eluting Bead in the Treatment of Chemo-Naïve Unresectable Colorectal
Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results of
Pharmacokinetics and Phase I Trial. J GI Surg 2012; Vol 16(8): 1531-38.
229. Martin RCG, McFarlin K, Ellis S, Velanovich V. Irreversible Electroporation Therapy
in the Management of Locally Advanced Pancreatic Adenocarcinoma. JACS 2012; Vol
215(3): 361-69.
CURRICULUM VITAE January 5th, 2014
44
230. O’Brien M, Pavlov V, Robbins K, Padr R, Martin RCG. Hepatic Arterial Therapy with
Drug eluting Beads in the management of Metastatic Renal Cell Carcinoma to the Liver:
a Multi-Institutional Registry. J Surg Rad 2012
231. Lee T, Martin RCG. Readmission Rates After Abdominal Surgery: Can They Be
Decreased to a Minimum? Advances in Surgery 2012. Vol 46:155-170
232. Cannon B, Scoggins CR, Callender G, McMasters KM, Martin RCG. Laparoscopic
Versus Open Resection of Hepatic Colorectal Metastases. Surgery 2012. Vol 152:567-
573
233. Fox M, von Berkel V, Bousamra M, Sloan S, Martin RCG. Surgical Management of
Pulmonary Carcinoid Tumors: Sub-lobar Resection versus Lobectomy. Am J Surg
2013.Vol 205(2):300-208
234. Bower M, Scoggins CR, McMasters KM, Martin RCG. Body Mass Index and Liver
Dysfunction Am J Surg 2013.
235. Li Y, Brown R, Li X, Martin RCG. Incomplete Thermal Ablation of Hepatocellular
Carcinoma Leads to Enhanced Cellular Viability and Resistance to Programmed Cell
Death. J Surg Res. Vol. 181(2):250-255
236. Rhodes Brown, Martin RCG. Management of Liver Dominant Metastatic Breast
Cancer: Surgery, Chemotherapy, or Hepatic Arterial Therapy – Benefits and Limitations.
Minerva Chirurgica 2012. Vol 67(4):297-308
237. Cannon RM, Ellis S, Hayes D, Narayanan G, Martin RCG. Safety and Early Efficacy of
Irreversible Electroporation for Hepatic Tumors in Proximity to Vital Structures. J Surg
Onc 2012. Vol 107(5):544-549
238. Martin RCG, R Salem, R Adam, E Dixon. Commentary Local regional surgical and
interventional therapies for advanced colorectal liver metastasis: expert consensus
statement. HPB 2013. Vol 15(2): 131-133.
239. Martin RCG, McFarland K, Ellis S, Velanovich V: Irreversible Electroporation in
Locally Advanced Pancreatic Cancer: Potential Improvement in Overall Survival. Ann
Surg Onc 2013. Vol 20 (S3):443-449.
240. Egger, M, Martin RCG. The Assessment of Chemotherapy Response in Colorectal Liver
Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic
Residual Viable Tumor. JACS 2012 Vol 216(4) :845-56
CURRICULUM VITAE January 5th, 2014
45
241. Edwards J, Scoggins CR, McMasters KM, Martin RCG. Combined Pancreas and Liver
Therapies: Resection and Ablation In Hepato-Pancreatico-Biliary Malignancies. J Surg
Onc 2012. Vol 107(7) 709-712
242. Miller A, St Hill CR, Ellis SF, Martin RCG. Health-Related Quality of Life Changes
Following Major and Minor Hepatic Resection: The Impact of Complications and Post-
operative Anemia. Am J Surg 2013. Vol 206(4):443-450.
243. Burnett NP, Dunki-Jacobs E, Callender GG, Anderson RJ, Scoggins CR, McMasters
KM, Martin RCG. Evaluation of AFP Staging System for Hepatocellular Carcinoma in
Non-cirrhotic Patients. Am Surgeon 2013. Vol 79 (7):716-22
244. Martin RCG. Irreversible Electroporation: A Novel Option for Treatment of Hepatic
Metastases. Current Colorectal Cancer Reports 2013 Vol 9(2):191-197.
245. Cannon RM, Scoggins CR, Callender G, Quillo A, McMasters KM, Martin RCG. A
Deviation Based Cost Modeling Analysis of Laparoscopic Versus Open Liver Resection.
Ann Surg Onc 2013. Vol 20(9): 2887-2892.
246. Lee T, Martin RCG. Surgical Quality of Care in Esophageal Malignancies. Future
Oncology 2012. Vol 9(4): 575-584.
247. Anderson R, Dunki-Jacobs E, Callender G, Burnett N, Scoggins CR, McMasters KM,
Martin RCG. Clinical Evaluation of Somatostatin Use in Pancreatic Resections: Clinical
Efficacy or Limited Benefit? Surgery 2014 154(4):755-760
248. Li Y, Shi W, Zhang J, Zhang X, Martin RCG. Hepatic Protection and Anti-cancer
Activity of Curcuma: A Potential Chemopreventive Strategy against Hepatocellular
Carcinoma. Int J Oncol 44: 505-513, 2014
249. Schiffman SC, Nowacki M, McMasters KM, Scoggins CR, Martin RC. Molecular
factors Associated with recurrence and Survival Following Hepatectomy in Patients with
Intrahepatic Cholangiocarcinoma: A Guide to Adjuvant Clinical Trials. J of Surg Onc
2014 Vol 109(2) Feb 2014:98-103
250. Mbah N, Scoggins CR, McMasters KM, Martin RCG. Impact of Hepatectomy Margin on
Survival following Resection of Colorectal Metastasis: The Role of Adjuvant Therapy and
Its Effects. Eur J Surg Onc Vol 39(12) Dec 2013:1394-1399.
251. Dunki-Jacobs, E, Philips P, Martin RCG. Evaluation of Resistance as a Measure of
Successful Tumor Ablation in Irreversible Electroporation of the Pancreas. JACS Feb
CURRICULUM VITAE January 5th, 2014
46
2014 Vol 218(2):179-187
252. Dunki-Jacobs EJ, Scoggins CR, McMasters KM, Martin RCG. Stroke Volume
Variation in Hepatic Resection: A Replacement for Standard Central Venous Pressure
Monitoring. Ann Surg Onc Feb 2014 Vol 21(2):473-78
253. Lencioni R, Aliberti C, de Baere T, Garcia-Monaco R, Narayanan G, O’Grady E, Riling
WS, Walker D, Martin RCG. Transcatheter Treatment of Colorectal Cancer Liver
Metastases with Irinotecan-Loaded DC Bead (DEBIRI): Technical Recommendations.
JVIR March 2014 Vol 25(3):365-369
254. Martin RCG, Cannon RM, Brown RE, Ellis SF, Williams S, Scoggins CR, Abbas A.
Evaluation of Quality of Life Following Placement of Self-Expanding Plastic Stents as a
Bridge to Surgery in Patients Receiving Neoadjuvant Therapy for Esophageal Cancer.
The Oncologist 2014 Vol 19(3):259-65
255. Anderson R, Dunki-Jacobs E, Burnett N, Scoggins CR, McMasters KM, Martin RCG. A
Cost Analysis of Somatostatin use in the Prevention of Pancreatic Fistula After
Pancreatectomy. W J Surg August 2014. Vol 38(8):2138-2144
256. Martin RCG, Philips P, Hayes D, Bagla S,. Irreversible Electroporation of Unresectable
Soft Tissue Tumors with Vascular Invasion: Effective Palliation. BMC Cancer. 2014,
14:540
257. Martin RCG. Irreversible Electroporation for Locally Advanced Pancreatic Cancer. J GI
Surg 2013. Vol 7(10):1850-1856
258. Philips P, Hayes D, Martin RCG. Irreversible Electroporation Ablation (IRE) of
Unresectable Soft Tissue Tumors: Learning Curve evaluation in the first 150 patients
treated. PLOS One Medicine 2013. Vol 8(11).
259. North AD, Schlegel M, Martin RCG. Gastroesophageal Reflux Disease-Related
Symptom Assessment in Subjects with Malignant Dysphagia receiving Esophageal
Stents. Am Surg December 2014. Vol 80(12):1260-1265
260. Li X, Li Y, States VA, Li S, Zhang X, Martin RCG. The effect of black raspberry
extracts on MnSOD activity in protection against concanavalin A induced liver injury.
Nutrition and Cancer: International Journal 2014. Vol 66(6):930-937
261. North AD, Groeschl RT, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C,
Rilling WS, TC Gamblin, Martin RCG. Microwave Ablation for Hepatic Malignancies:
A Call for Standard Reporting and Outcomes. Am J Surg 2014. Vol 208(2):284-294
CURRICULUM VITAE January 5th, 2014
47
262. Dunki-Jacobs EJ, Scoggins CR, McMasters KM, Martin RCG. Evaluation of Thermal
Injury to Liver, Pancreas, and Kidney during Irreversible Electroporation in an In-vivo
Porcine Model. Br J Surg 2014. Vol 101(9):1113-1121
263. Philips P, Farmer R, Scoggins CR, McMasters KM, Martin RCG. Caudate Lobe
resections: A single center experience and evaluation of factors predictive of outcomes.
W Journal Surg Onc 2013:11:220
264. Agle S, Philips P, Martin RCG. Environmental Exposures, Tumor Heterogeneity, and
Colorectal Cancer Outcomes. Curr Colorect Reports 2013 Vol 10(2): 189-194
265. Bruenderman E, Martin RCG. High-Risk Population in Sporadic Pancreatic
Adenocarcinoma: Guidelines for Screening. J Surg Res 2014 In Press
266. Wehry J, Cannon B, Scoggins CR, Puffer L, McMasters KM, Martin RCG. Restrictive
Blood Transfusion Protocol in Liver Resections Patients Reduces Blood Transfusions
with No Increase in Patient Morbidity. Am J Surg 2014. In Press
267. Philips P, Dunki-Jacobs E, Agle SC, Scoggins CR, McMasters KM, Martin RCG. The
role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a
selection criterion for surgery. HPB. 2014 Vol 16(12):1051-1055
268. Doughtie CA, Priddy EE, Philips P, Martin RCG, McMasters KM, Scoggins CS.
Preoperative dosing of low-molecular weight heparin in hepatopancreatobiliary surgery.
The Am J of Surg. 2014 Vol 208(6):1009-1015
Accepted for Publication
1. Martin RCG, Schwartz E, Adams J, Farah I, Derhake B. Intra-operative Anesthesia
Management in Patients Undergoing Surgical Irreversible Electroporation of the
Pancreas, Liver, Kidney, and Retroperitoneal Tumors. Anesthesia and Pain, 2014
2. Akinwande OK, Martin RCG. Small (75-150 microns) versus medium sized drug
eluting beads (DEBIRI) for the treatment of colorectal metastases – A Multi-institutional
propensity score matching analysis. CVIR 2014
3. Akinwande OK, Miller AR, Martin RCG. Concominant Capecitabine with Hepatic
Arterial Infusion of Drug Eluting Beads in the management of metastatic colorectal
cancer: A Multi-Institutional prospective study. – Anti Cancer Research 2014
CURRICULUM VITAE January 5th, 2014
48
4. Bruedermann E, Martin RCG. A Cost Analysis of a Pancreatic Cancer Screening
Protocol in High-Risk Populations. Am J of Surg 2014
5. Kwon D, McFarland K, Velanovic V, Martin RCG. Borderline and Locally Advanced
Pancreatic Adenocarcinoma Margin Accentuation with Intra-Operative Margin
Accentuation. Surgery 2014. Vol 156(4):910-922
6. Martin RCG Irreversible Electroporation in Locally Advanced Pancreatic
Adenocarcinoma Body/Neck – Technique Paper. J of Gastrointestinal Oncology 2015
Submitted for Publication
1. Lu Z, Li Y, Takwi A, Conklin D, Martin RCG, Li Y. A MicroRNA-Mediated NF-
kappaB Activation in Pancreatic Cancer Cells. J Nat Ca Institute 2008.
2. St Hill CR, Brown R, Scoggins CR, McMasters KM, Martin RCG. Operative Duration
and the Effects on Perioperative Outcomes after Pancreaticoduodenectomy.
Hepatogastroenterology 2012.
3. Farmer RW, Scoggins CR, McMasters KM, Martin RCG. Factors Predictive of Adverse
Outcomes in Gallbladder Cancer. W J Surg 2012.
4. St Hill CR, Mbah NA, Cannon R, Brown R, Kooby D, Staley C, Cho CS, Weber S,
Winslow S, Scoggins CR, McMasters KM, Martin RCG. Laparoscopic versus Open
Resection for Hepatocellular Carcinoma: Improvement in Outcomes and Similar Cost.
Surgical Endoscopy 2013.
5. Martin RCG. 2013 State of the Art Lecture: Evolving Management in Pancreatic
Cancer: Use of Irreversible Electroporation in Unresectable Pancreatic Cancer.
Hepatobiliary Surgery and Nutrition 2014.
6. Akinwande OK, Ahmad SS, Van Meter T, Schultz B, Martin RCG. Irreversible
Electroporation in Locally Advanced Pancreatic Cancer: CT Findings in “Typical”
Post-IRE Changes vs Local Recurrence”. Acta Radiologica
7. Oliver A, Martin RCG. Evaluating the PK/PD and clinical efficacy of DC Bead - a
doxorubicin- eluting polymer for treating liver cancer. Expert Opinion On Drug
Metabolism and Toxicology 2014
8. Martin RCG, Locatelli E, Li Y, Weizhong Z, Li S, Monaco I, Comes-Franchini M.
CURRICULUM VITAE January 5th, 2014
49
Gold Nanorods and Curcumin-Loaded Nanomicelles for efficient in vivo Photothermal
Therapy of Barrett’s Esophagus. ACS Nanomedicine 2014.
9. Akinwande OK, Kim D, Edwards J, Brown R, Philips P, Scoggins CR, Martin RCG.
Comparative analysis of transarterial therapy for unresectable hepatocellular carcinoma
with portal vein thrombosis: Radioembolization (90Y) versus doxorubicin drug eluting
beads (DEBDOX). Surgical Oncology
BOOK CHAPTERS
1. Martin RCG, Karpeh M. An Internist’s Illustrated Guide to Gastrointestinal Surgery:
Surgical Management of Gastric Tumors. The Humana Press, INC. Totowa, NJ. 2003.
2. Martin RCG, McMasters KM. Surgical Complications, Risks and Consequences:
Textbook Surgery: Complications, Risks and Consequences 7-Volume Series. Chapter -
Surgery: Complications, Risks and Consequences - Upper Abdominal Surgery (ISBN-13:
978-1447154358) - Springer
3. Martin RCG, Kidd L, Hein DH. Colo-rectal Cancer Susceptibility: The Role of
Polymorphic N-Acetyltransferase Genes (NAT1 and NAT2), Heterocyclic Aromatic
Amines, and Gene-diet Interactions. CRC Press LLC 2005.
4. Scoggins CR, Martin RCG, McMasters KM. Duodenal Cancer. In: Pollock RE, Curley
SA, Ross MI, Perrier ND, editors. Advanced Therapy in Surgical Oncology, 1st Edition:
Pp. 229-235.
5. Yan Li, MD, PhD and Robert C.G. Martin, II, MD, PhD. Apoptosis in Carcinogenesis
and Chemotherapy: Esophageal cancer. In: Apoptosis in Carcinogenesis and
Chemotherapy, Editor George G Chen, MD, PhD, 1st Edition, Springer 2009.
6. Schiffman S, Martin RCG. CT- and MR-guided Interventions in Radiology: Chapter 13
Technical basics of Microwave ablation. 2nd Edition, Springer 2011
7. Robert C.G. Martin, II, MD, PhD, Hepatocellular Cancer, Springer 2009 Editors Kelly
M. McMasters, MD, PhD and Jean-Nicholas Vauthey, MD, FACS
Chapters:
Chapter 8: Hepatocellular Carcinoma Arising in the Non-Viral, Non-Alcoholic Liver
Chapter 18: Microwave Ablation
Chapter 20: Chemoembolization with Drug-Eluting Beads
8. St. Hill CR, Brown R, Martin RCG. Video Atlas of Advanced Minimally Invasive
CURRICULUM VITAE January 5th, 2014
50
Surgery, Elsevier 2011, Editor: Mark Carlson
Chapter 17: Laparoscopic Liver Resection
9. Fouad H, Martin RCG. Regional Cancer Therapy for Advanced Tumors Jaypee
Brothers Medical Publishing, 2011, Editor: Martin Goodman
Chapter: Hepatic Arterial Therapies for Colorectal Metastases
10. Suzanne C. Schiffman, MD and Robert C.G. Martin, II, MD, PhD. Arteriovenous
Fistulae and Aneurysms of the Hepatic and Pancreatic Vasculature.In: LH Blumgart,
editor. Surgery of the Liver, Biliary Tract and Pancreas. Fifth Edition. Elsevier Health
Sciences.
11. Woodall CE, Martin RC, McMasters KM, Scoggins CR. Hepatocellular carcinoma
arising in the non-viral, non-alcoholic liver. In: McMasters KM, Vauthey JN, eds.
Hepatocellular carcinoma: Targeted therapy and multidisciplinary care. New York:
Springer, 2011:99-108.
12. Schiffman S, Martin RCG. CT- and MR-guided interventions in radiology (Chapter 13)
In:
Technical Basics of Microwave Ablation; 2nd ed. New York: Springer, 2011.
13. Philips, P, Martin RCG. Technical Considerations in Liver Surgery. Handbook of
Pancreas and Hepatobiliary Surgery, 1st Edition. Lippincott 2013.
14. Phillips P, Li Y, Martin RCG. Chapter 23: Low Energy DC currrent ablation in a
mouse tumor model. 2nd Edition of Electroporation Protocols: Preclinical and Clinical
Gene Medicine. Book: Electroporation Protocols: Preclinical and Clinical Gene
Medicine. Springer Science Business Media, New York, NY, 2014
15. Shumer E, Martin RCG. Chapter: Minimally Invasive Feeding Tube andEsophageal
Stent Placement. Book: Minimally Invasive Foregut Surgery: Principles and Practices.
2014
16. Spaulding T, Martin RCG. Chapter: Gastroienteropathic Neuroendocrine Tumors.
Book: Current Controversies in Cancer Care for the Surgeon. Springer Science and
Business Media, New York, NY 2014
OTHER PUBLICATIONS
1. Hilar Cholangiocarcinoma and Gallbladder Cancer: Surgical Management. Martin RCG,
Post-Graduate Course 16, American College of Surgeons, 88th clinical congress. Oct 6th-
10th, 2002 pg 26-28.
CURRICULUM VITAE January 5th, 2014
51
2. Martin,R.C.G., Hughes,K., Doll,M.A., Rothmann,N. and Hein,D.W. -102
polymorphism present at the -102 position from the transcription start site of the MnSOD
gene. Genebank Bankit #574003, AY397775. Homo sapiens Manganese Superoxide
Dismutase partial 5' UTR.
BOOK REVIEWS
1. Atlas of General Surgery. Am J Surg 174:570, 1997.
SPEAKER PRESENTATIONS
International:
1. DC/LC Bead Open Surgical Registry in Primary and Metastatic Liver Tumors. European
Conference of Interventional Oncology and Embolotherapy. Palazzo dei Congessi,
Florence, Italy April 10th, 2008.
2. DC/LC Bead Open Surgical Registry: The Power of A Registry. European Conference of
Interventional Oncology and Embolotherapy. Hotel Brunelleschi Florence, Italy April
11th, 2008.
3. DC/LC Bead Treatment for Neo-adjuvant for resectable and marginally resectable
Hepatocellular. International Liver Cancer Association (ILCA), Chicago, IL, September
5th, 2008.
4. DC/LC Bead Interim Analysis is Neoadjuvant Therapy for Metastatic Colorectal Cancer.
14th Congress of the European Society of Surgical Oncology, The Hague, The
Netherlands, September 10-12th, 2008.
5. LC/DC Bead Registry: Management in Metastatic and Primary Cancer of the Liver. 10th
Congress of the Cardiovascular and Interventional Radiological Society of Europe,
Copenhagen, Sweden, September 16th, 2008.
6. Toxicity of irinotecan eluting beads in the treatment of hepatic malignancies: results of
multi-institutional registry. 11th Congress of the Cardiovascular and Interventional
Radiological Society of Europe, Lisbon, Portugal September 20th, 2009.
7. Review of 350 Patient Drug Eluting Bead Registry: Breast, Melanoma,
Cholangiocarcinoma and Esophageal. 11th Congress of the Cardiovascular and
Interventional Radiological Society of Europe, Lisbon, Portugal September 20th, 2009.
CURRICULUM VITAE January 5th, 2014
52
8. Inovations in Surgical Resection and Loca-Regional Therapies Symposium: Topic Non-
Thermal Ablation using irreversible electroporation (IRE): initial USA Clinical
Experience. 9th World Congress of the Internation Hepato-Pancreatico-Biliary
Association, April 18th-22nd , 2010 – Buenos Aires, Argentina
9. Inovations in Surgical Resection and Loca-Regional Therapies Symposium: Topic
Thermal and Non-Thermal Ablation of the Pancrease – Past Clinical and Recent Pre-
Clinical Experience. 9th World Congress of the Internation Hepato-Pancreatico-Biliary
Association, April 18th-22nd , 2010 – Buenos Aires, Argentina
10. Pre Congress Course – Multimodality Treatment of HPB Tumors: Topic Yttrium labled
microsphers inneuroendocrine metastases. 9th World Congress of the Internation Hepato-
Pancreatico-Biliary Association, April 18th-22nd , 2010 – Buenos Aires, Argentina
11. Latest Clinical and Pathological result of Drug-Eluting Beads in the management of
metastatic colorectal and hepatocellular carcinoma Symposium: Topic Drug Eluting
Bead, Irinotecan (DEBIRI) Therapy of liver Metastasis from Colon Cancer with
Concomitant FOLFOX-6 and anti-Angiogenic Therapy. 9th World Congress of the
Internation Hepato-Pancreatico-Biliary Association, April 18th-22nd , 2010 – Buenos
Aires, Argentina
12. Treatment of chemo naive colorectal liver metastasis by using irinotecan drug eluting
bead with concomitant systemic fluorouracil and oxaliplatin. 12th World Congress on
Gastrointestinal Cancer, June 30th – July 3rd, 2010, Barcelona, Spain
13. Current Concepts in the Treatment of Colorectal Hepatic Metastasis – ECIO meets
ESMO: Conventional Chemoembolization and Drug Eluting Beads. 2nd European
Conference on Interventional Oncology. July 21-24th, 2010, Florence, Italy
14. LC/DC Bead – How to Select Patients and Optimize Outcomes – Satellite Symposium:
DC Bead in Metastatic Disease: DEBIRI in Combination with Systemic Chemotherapy:
The optimal management of liver dominant disease. 2nd European Conference on
Interventional Oncology. July 21-24th, 2010, Florence, Italy.
15. Irreversible Electroporation: The next frontier for focal ablative therapy – Satellite
Symposium: Non-Thermal Ablation using irreversible electroporation: The initial US
Experience. 2nd European Conference on Interventional Oncology. July 21-24th, 2010,
Florence, Italy.
16. Moderator and Chairman at the Expert Meeting of Drug Eluting Bead Technology:
Treatment of Primary and Secondary Liver Cancer with Chemotherapy-Eluting Beads.
CURRICULUM VITAE January 5th, 2014
53
Presentation – The Rationale for Irinotecan Drug Eluting Bead Therapy in Metastatic
Colorectal Cancer, Empire Riverside Hotel, July 26th, Hamburg, Germany.
17. Treatment of Primary and Secondary Liver Cancer with Chemotherapy-Eluting Beads.
Presentation the Multidisciplinary Management of Atypical Metastatic Disease to the
Liver, Empire Riverside Hotel, July 26th, Hamburg, Germany.
18. Drug Eluting Bead Therapy – for Primary and Metastatic Disease to the Liver. Mount
Elizabeth Hospital, Singapore, September 29th, 2010.
19. Optimal Hepatic Arterial Therapy for Primary and Metastatic Disease to the Liver.
National University Hospital and Tan Tock Seng Hospital Multidisciplinary Conference,
Singapore, September 29th, 2010.
20. Drug Eluting Bead Therapy – for Primary and Metastatic Disease to the Liver. Annual
Scientific Congress Malaysian Oncological Society (ASCOMOS), Kota Bahru, Malaysia
September 30th, 2010.
21. Optimal Combination Systemic and Hepatic Arterial Therapy in Metastic Disease to the
Liver. Annual Scientific Congress Malaysian Oncological Society (ASCOMOS), Kota
Bahru, Malaysia, September 30th, 2010.
22. DC BeadM1 managing metastatic disease: Clinical rationale and pilot data. 12th
Congress of the Cardiovascular and Interventional Radiological Society of Europe,
Valencia, Spain October 2nd, 2010.
23. Oncology Conference and Treatment planning Conference. Novel Treatments in the
Management of Unresectable Metastatic Colorectal Cancer. Instituto Nacional de Câncer
– INCA, Rio de Janerio, Brazil, June 28th, 2011.
24. Oncology Grand Rounds The treatment of hepatic tumors, the chemoembolization, their
indications, results and applications. Hospital Santa Rita - Sta. Casa de Porto Alegre,
Brazil. June 29th, 2011
25. Oncology Tumor Board – Grand Rounds. Multi-Disciplinary Management of Metastatic
Colorectal Cancer. Hospital de Clinicas de Porto Alegre. Porto Alegre, Brazil. June 29th,
2011
26. Oncology Multi-Disciplinary Treatment Conference. Update in treatment of metastatic
tumors to the liver: Chemoembolization - indications and results. Hospital Mae de Deus,
Instituto do Cancer, HCPA, Hospital Conceicao, PUCRS. Porto Alegre, Brazil. June
29th, 2011.
CURRICULUM VITAE January 5th, 2014
54
27. Chiliean – Americas Hepato-Pancreatico-Biliary Post Graduate Course. New
Technologies for Liver-Directed Therapy: Microwave Ablation, Radioembolization and
Drug-Eluting Beads. Clinical Alemana, Santiago, Chile, July 1st, 2011.
28. Oncology Tumor Board - Multi-Disciplinary Management of Metastatic Colorectal
Cancer. Hospital AC Carmago, Sao Paulo, Brazil, August 9th, 2011.
29. Oncology Tumor Board - Multi-Disciplinary Management of Metastatic Colorectal
Cancer. Hospital Albert Enstein, Sao Paulo, Brazil, August 10th, 2011.
30. Society Brazil of Radiology Interventional, Cardiology, and Endovascular (SoBRICE).
Drug Eluting Beads and Transarterial Chemoembolization in HCC prior to resection and
transplant. Buzios, Brazil August 11, 2011.
31. Society Brazil of Radiology Interventional, Cardiology, and Endovascular (SoBRICE).
Decision making strategies for resection and the role of loco regional therapies in
metastatic colorectal cancer. .Buzios, Brazil August 11, 2011.
32. Society Brazil of Radiology Interventional, Cardiology, and Endovascular (SoBRICE).
Ablative Therapies for Metastatic Colorectal Cancer. Buzios, Brazil August 11, 2011.
33. Society Brazil of Radiology Interventional, Cardiology, and Endovascular (SoBRICE).
Drug Eluting beads in the management of Metastatic Colorectal Cancer. Buzios, Brazil
August 11, 2011.
34. Asian Pacific HPBA Congress. The use of Irinotecan Drug Eluting Beads: A Surgeons
Perspective. Melbourne, Australia, September 29th, 2011.
35. The Interdisciplinary Treatment of Liver Tumors (ITLT) – Chairman of Session: Liver
Metastasis of Colorectal Cancer. The Atlantic Conference Center, Essen Germany,
October 29th, 2011.
36. The Interdisciplinary Treatment of Liver Tumors (ITLT) – Speaker at Session: Liver
Metastasis of Colorectal Cancer: Chemoembolization of colorectal liver metastasis:
conventional or drug eluting beads. The Atlantic Conference Center, Essen Germany,
October 29th, 2011.
37. Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011 –
Munich, Germany September 18th, 2011 – Updates in Irreversible Electroporation of the
Liver and Pancreas – Results Multi-institutional Registry.
CURRICULUM VITAE January 5th, 2014
55
38. The third European Conference on Interventional Oncology, ECIO 2012, April 25, 2012
in Florence, Italy. Is there a place for local chemotherapy to the liver?
39. The third European Conference on Interventional Oncology, ECIO 2012, April 25, 2012
in Florence, Italy. Irreversible Electroporation in Locally Advanced Pancreatic Cancer.
40. Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012 –
Lisbon, Portugal September 18th, 2012 – Interim results of a first-line evaluating DEBIRI
in combination with FOLFOX and Avastin in Colorectal Liver Metastasis.
41. The European Society of Surgical Oncology 32nd Congress, Valencia, Spain September
19th, 2012 – Embolic Drug Eluting Beads in the Management of Colorectal Liver
Metastasis.
42. SHOW – Symposium on Hepatic Oncology, 2nd Annual Meeting, Whistler, Ontario
Canada, February 1st, 2013 - Ablation Nation: Do we need new ablation technologies?
What do they add?
43. SHOW – Symposium on Hepatic Oncology, 2nd Annual Meeting, Whistler, Ontario
Canada, February 2nd, 2013 - How much liver can you take out?: Preop optimization
techniques: downstaging and PVE.
44. SHOW – Symposium on Hepatic Oncology, 2nd Annual Meeting, Whistler, Ontario
Canada, February 1st, 2013 – Sequencing of Locoregional Therapy and Chemo for HCC.
45. Fourth European Conference on Interventional Oncology (ECIO), June 22nd, 2013,
Budapest, Hungary – Drug Eluting Beads in Metastatic Colorectal Cancer.
46. Fourth European Conference on Interventional Oncology (ECIO), June 22nd, 2013,
Budapest, Hungary – Optimal Management in Metastatic Colorectal Cancer- Tumor
Board Discussion.
47. Chariperson – Moderator for IHPBA 11th World Congress 2014, Seoul, Korea, March
24th, 2014 – Various Issues in Colorectal Liver Metastasis
48. Invited Speaker to the IHPBA 11th World Congress 2014, Seoul Korea, March 23rd,
2014 – Session: Updates in Image-Guided and Computer-Assisted Liver Surgery –
Optimal Intra-operative navigation for Irreversible Electroporation of Locally Advanced
Pancreatic Cancer.
49. International Academic Conference on Irreversible Electroporation in Tumor Ablation.
May 10th 2014, 301 Military Hospital Beijing China. Optimal Patient Selction and
CURRICULUM VITAE January 5th, 2014
56
Outcomes for IRE in Liver and Pancreatic Tumors.
50. International Academic Conference on Irreversible Electroporation in Tumor Ablation.
May 11th 2014, Prince of Wales Hospital, Chinese Medical University, Hong Kong
China. Optimal Patient Selction and Outcomes for IRE in Liver and Pancreatic Tumors.
51. CIRSE, 2014 Annual Meeting, Sept 13th-17th, Glasgow Scotland – Pancreatic Tumors
Irreversible Electroporation.
52. CIRSE, 2014 Annual Meeting, Sept 13th-17th, Glasgow Scotland – Chair, moderator of
session - MRI Gated Focuses Ultrasound and IRE.
53. The 10th Chinese Conference of Minimally Invasive Therapy in Oncology / The 1st
Scientific Meeting of Asia Pacific Association of Imaging Guided Therapy in Oncology –
Shanghai, China, Nov 7th 2014 – IOUS-Guided Tumor Ablation – History, Current
Situation, and Future
54. 2014 Capital Ultrasound Forum / The 2nd Ultrasonic Medical Academic Conference –
Beijing, China Nov 8th 2014. – 3D Ultrasound Enhanced Imaging in Advanced Liver and
Pancreatic Ablations
55. Workshop of Intraoperative Ultrasonography in Hepatobiliary Surgery – Beijing China,
Nov 8th 2014 – Novel Intra-operative Ultrasound Techniques for Liver Ablation
National:
56. Hilar Cholangiocarcinoma and Gallbladder Cancer: Surgical Management. Post-Graduate
Course 16, 88th Congress, American College of Surgeons, San Francisco Oct 6th-10th,
2002.
57. Blood Utilization in Surgical Oncology. Ortho Biotech Surgery – Johnson and Johnson
2006 Summit, Phoenix AZ, April 2006.
58. Ablative Approaches to Pulmonary, Renal, and Bone Tumors. The Society of Surgical
Oncology Annual Meeting, San Diego, CA, March 2006.
59. Optimal Multimodality Care of Esophageal Cancer. Boston Scientific National Sales
Meeting. Orlando, FL, January 31st, 2007.
60. New Uses in Esophageal Stenting for the treatment of Esophageal Diseases: Benign and
Malignant. Boston Scientific National Marketing Meeting. Sanibel Island, FL, March
8th, 2007.
CURRICULUM VITAE January 5th, 2014
57
61. Moderator, Optimizing the Management of Anemia in Cancer Surgery. Society of
Surgical Oncology, 60th Annual Cancer Symposium, Washington, D.C., March 15th-
18th, 2007.
62. The Use of Intra-operative Auto-transfusion in Surgical Oncology: A True Contra-
indication? Society of Surgical Oncology, 60th Annual Cancer Symposium, Washington,
D.C., March 15th-18th, 2007. Invited speaker: Interventional Radiology Symposium,
Little Rock, Arkansas, May 15th, 2007: New Modalities in the Treatment of Primary and
Secondary Liver Cancer.
63. Invited speaker to the SAGES and AHPBA 2007 Scientific Session, April 18-22, 2007,
Las Vegas, NV: SAGES/ AHPBA Panel: Contemporary Issues and Outcomes: Hepatic
Tumor Ablation: The Physics of Ablation.
64. Invited discussant Oral Presentation AHPBA2007 Scientific Session, April 18-22, 2007,
Las Vegas, NV: remote ischemia preconditioning modulates hepatic microcirculation
through the hemeoxygenases pathway in a rat model of warm ischemia reperfusion injury
of the liver.
65. Invited discussant Oral Presentation AHPBA2007 Scientific Session, April 18-22, 2007,
Las Vegas, NV: Guidelines for power and time variables for Microwave Ablation in a
porcine liver
66. Invited discussant Oral Presentation AHPBA2007 Scientific Session, April 18-22, 2007,
Las Vegas, NV: Factors influencing Perioperative Blood Transfusion in Patients
undergoing Major Hepato-Pancreatico-Biliary procedures.
67. Moderator of World Congress Interventional Oncology, Washington DC in May 14-17th,
2007. RFA and Embolization for the Management of soft Tissue Malignancies: liver and
breast.
68. Invited Speaker to World Congress Interventional Oncology, Washington DC in May 14-
17th, 2007. Laparoscopic Hepatic Resections with a Novel Surgical Device: the Habib
4X
69. Invited Speaker to Huntsville Alabama, Clinical Research Meeting, July 26th, 2007. New
Hepatic Arterial Modalities in the Treatment of Primary/ Secondary Liver Cancer.
70. Invited Speaker to University of Florida, Shands, Jacksonville, Division of Surgical
Oncology Grand Rounds August 22, 2007. Novel Treatments in Esophageal
Adenocarcinoma.
CURRICULUM VITAE January 5th, 2014
58
71. Invited Speaker to University of Florida Interventional Radiology Oncology Seminar,
Gainesville, FL, September 6th, 2007. Novel Treatments in the Hepatic Intra-arterial
Therapy of the Liver.
72. Guest Faculty to Carolinas Medical Center, Mini-Fellowship for Hepatic Radiofrequency
Ablation, Charlotte, NC September 16-17th.
73. Invited Speaker Carolinas Medical Center, Mini-Fellowship for Hepatic Radiofrequency
Ablation, Charlotte, NC September 16th. Radiofrequency Ablation for Colorectal Hepatic
Metastasis.
74. Invited Speaker Carolinas Medical Center, Mini-Fellowship for Hepatic Radiofrequency
Ablation, Charlotte, NC September 17th. Microwave Ablation for Primary and
Secondary Hepatic Tumors.
75. University of North Carolina Gastroenterology Grand Rounds, September 18th, 2007.
Invited Speaker: Novel Endoscopic Therapies in Esophageal Adenocarcinoma.
76. Hulston Cancer Center Symposium, Springfield, MO, September 21st, 2007. Invited
Speaker: Advances in the Multi-Disciplinary Care of Hepatic and Pancreatic Cancers.
77. Duke University Multi-disciplinary Gastrointestinal Grand Rounds, Raleigh, NC,
October 11th, 2007. Invited Speaker: Novel Endoscopic Therapy in Esophageal
Adenocarcinoma.
78. 93rd Annual Clinical Congress of the American College of Surgeons, Current
Management of Hepatoma Session, October 10th, 2007 New Orleans, LA. Invited
Speaker: Non-operative, non-ablative therapies for hepatoma: Embolization,
chemoembolization, and radioactive microsphere treatment, systemic therapy, and more.
79. Kansas University Interventional Hepatic Therapy Grand Rounds, October 31st, 2007
Kansas City, Kansas. Invited Speaker: Novel Hepatic Arterial Therapies for Primary and
Secondary Liver Tumors.
80. Medical College of Georgia Department of Surgery, Upper Gastrointestinal Multi-
disciplinary Grand Rounds, November 2, 2007, Augusta, GA. Invited Speaker: Novel
Endoscopic Therapies in Esophageal Adenocarcinoma.
81. St. Clare Regional Hospital/ Thompson Cancer Center Grand Rounds, November 12th,
2007, Knoxville, TN. Invited Speaker: Novel Hepatic Arterial Therapies for Primary and
Secondary Liver Tumors.
CURRICULUM VITAE January 5th, 2014
59
82. Tampa General Hospital Interventional Radiology Department, Cancer Conference,
November 15th, 2007, Tampa, FL. Invited Speaker: Recent Advances in TransArterial
Embolization for Primary and Metastatic Liver Cancer.
83. Piedmont Hospital System Tumor Board, Cancer Conference, November 28th, 2007,
Atlanta, GA. Invited Speaker: Recent Advances in TransArterial Embolization for
Primary and Metastatic Liver Cancer.
84. Trinity Hospitals Tumor Board, Cancer Conference, December 13th, 2007, Minot, ND.
Invited Speaker: Advances in the Surgical Quality of Colon Cancer.
85. The Society of Surgical Oncology 61st Annual Cancer Symposium, March 13th Sheraton
Chicago Hotel, Chicago, IL. Microwave Ablation of Liver Tumors: Results of Clinical
Trials.
86. Louisiana State University, Cancer Conference, May 14th, 2008, Shreveport, LA.
Invited Speaker: Advances in Hepatic Arterial Therapy for Primary and Metastatic Liver
Cancer.
87. Distinguished Speaker: Contrast Enhanced Hepatic Ultrasound, B-K Medical Systems
Colon Rectal Focus Group, Kennebunkport, ME, August 9-10th, 2008.
88. Mount Sinai Medical Center / Miami Heart Institute, October 3rd, 2008, Miami, FL.,
Invited Speaker, Tumor Board: Interim Analysis of International LC/DC Bead Registry
for Primary and Metastatic Lesions to the Liver.
89. Postgraduate Course Southeastern Surgical Congress, February 7th, 2009, Atlanta, GA,
Clinical Dilemmas in Cancer Surgery: Vascular Resections in Pancreatic Cancer
90. Postgraduate Course Southeastern Surgical Congress, February 7th, 2009, Atlanta, GA,
Clinical Dilemmas in Cancer Surgery: Laparoscopic Resection of Liver Tumors
91. Postgraduate Course Southeastern Surgical Congress, February 7th, 2009, Atlanta, GA,
Clinical Dilemmas in Cancer Surgery: Treatment of Unresectable Liver Tumors:
Radiofrequency and Microwave Ablation, Intra-arterial Radiotherapy and Chemotherapy
92. The Association for Academic Surgery – Fall Leadership Course, October 10th, 2009,
Chicago, IL - Choosing the Right Job and Negotiating for Academic Success
93. The Academic Surgical Congress: Hot Topic Symposium: Liver Tumors: Expert Update:
Treating Primary and Secondary Hepatic Malignanices with Radiofrequency or
CURRICULUM VITAE January 5th, 2014
60
Microwave Ablation: Patient Selection and Outcomes. February 5th, 2010, San Antonio,
TX.
94. The Academic Surgical Congress: Instructor: Animate Hands-on Session: Beginner and
Advanced Liver Ultrasound Modules. February 5th, 2010, San Antonio, TX.
95. The Society of Surgical Oncology: Symposium Speaker: Optimizing Outcomes in
Metastatic Gastrointestinal Neuroendocrine Tumors. March 7th, 2010, St. Louis, Mo
96. The 6th Fire, Ice and Beyond: The Future of Ablation Therapies. Electroporation: Which
Patients and Why? Encore at Wynn Las Vegas, La Vegas, Nevada Sept 23-24, 2011
97. The 6th Fire, Ice and Beyond: The Future of Ablation Therapies. All These Interventional
Options: Where Does the Surgeon Fit In? – Philosophical Concepts? Encore at Wynn
Las Vegas, La Vegas, Nevada Sept 23-24, 2011
98. The 6th Fire, Ice and Beyond: The Future of Ablation Therapies. Cancer Therapies: A
Multidisciplinary Approach. Encore at Wynn Las Vegas, La Vegas, Nevada Sept 23-24,
2011.
99. The 97th American College of Surgeons Annual Meeting – Moderator - Management of
Complex Cancers: Upper GI Tumors. Moscone Center, San Francisco, CA October 25th,
2011.
100. The 97th American College of Surgeons Annual Meeting – Speaker- Management of
Complex Cancers: Upper GI Tumors. Topic Surgical Management of GI Neurendocrine
Tumors. Moscone Center, San Francisco, CA, October 25th, 2011.
101. Updates in Ablation Therapy – Thermal to Non-Thermal Modalities. Dekalb Angio Club,
Atlanta, GA, November 8th, 2011.
102. Irreversible Electroporation – Initial Results in the treatment of locally advanced
pancreatic cancer – planned Phase II Trial. AHPBA National Meeting, Eden Roc, Miami
FL., March 7th, 2012.
103. Optimal management of metastatic neuroendocrine tumors with oral-targeted agents and
long-acting injection. 65th Annual Cancer Symposium – Society of Surgical Oncology,
Orlando World Congress, Orlando, FL, March 22nd 2012.
104. Surgery for Non-Invasive Disease: Does it Save Lives? Barrett’s Esophagus. 65th Annual
Cancer Symposium – Society of Surgical Oncology, Orlando World Congress, Orlando,
FL, March 22nd 2012.
CURRICULUM VITAE January 5th, 2014
61
105. Interactive Tumor Board – Colorectal Cancer – with and without Liver metastasis. 65th
Annual Cancer Symposium – Society of Surgical Oncology, Orlando World Congress,
Orlando, FL, March 24nd 2012.
106. Analogic Investor Education Day – NASDAQ – “Ultrasound Guidance – Essential Tool
in the Operating Room”. October 4, 2012, New York, NY.
107. Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Improved Local
Control and Quality of Life: Department of Surgery Grand Rounds – Wake Forest
University – Bowman Grey Hospital, Winston Salem NC, October 31st 2012.
108. Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Improved Local
Control and Quality of Life: Department of Surgery Carolinas Medical Center, Charlotte,
NC, October 31st 2012.
109. Current Trial in DEBIRI. SYNERGY 2012: A Multidisciplinary Approach to
Interventional Oncology, Miami, FL. November 10th, 2012.
110. Surgical Ablation of Pancreatic Cancer. SYNERGY 2012: A Multidisciplinary Approach
to Interventional Oncology, Miami, FL. November 11th, 2012.
111. Ultrasound Methods of Tumor Ablation in HPB Surgery. AHPBA National Meeting,
Eden Roc, Miami FL., February 20th, 2013.
112. What Are The Most Important Clinical Questions? How to Access What is Most
Relevant to our Members. AHPBA National Meeting, Eden Roc, Miami FL., February
22th, 2013.
113. Predictors of Readmission and Quality Parameters in Liver Surgery. AHPBA National
Meeting, Eden Roc, Miami FL., February 22th, 2013.
114. Safety of Hepatectomy after Yttrium-90 Therapy. AHPBA National Meeting, Eden Roc,
Miami FL., February 22th, 2013.
115. Electroporation of Liver and Pancreas: Still Experimental or Accepted Practice? A
Opinion. AHPBA National Meeting, Eden Roc, Miami FL., February 22th, 2013.
116. Advanced energy/laparoscopy in Pancreatic – Esophagogastric Surgery. 66th Annual
Society of Surgical Oncology Caner Symposium. New Harbor MD, March 7th, 2013
117. STATE OF THE ART CONFERENCE: Pancreas – 54th Annual Meeting – The Society
CURRICULUM VITAE January 5th, 2014
62
for Surgery of the Alimentary Tract, May 19th, 2013, Orlando Fl. The Use of Irreversible
Electroporation in Unresectable Pancreatic Cancer.
118. Hepatic Tumor Ablation Technologies – 2nd Annual AHPBA Fellows Minimally
Invasive Surgery Course – August 19th, 2013
119. Laparoscopic Pancreatic Resection - 2nd Annual AHPBA Fellows Minimally Invasive
Surgery Course – August 19th, 2013
120. DEBIRI – Update on Clinical Trials and Results, 3rd Annual SYNERGY Meeting, Eden
Roc, FL – October 19th 2013
121. Margin Accentuation in Pancreatic Cancer – Results and Outcomes, 3rd Annual
SYNERGY meeting, Eden Roc Fl, October 19, 2013
122. Surgical Management of Metastatic Colorectal Trials and Metastatic Neuroendocrine
Tumors. Symposium on the Management of Liver Metastasis, Methodist Dallas Medical
Center / Methodist Health System Clinical Research Institute, October 26th, 2013
123. Ultrasound Methods in Tumor Ablation – 2014 Annual Meeting Americas Hepato-
Pancreatico-Biliary Association, Eden Roc, Miami FL.
124. US Coding and Billing for the Surgeon - – 2014 Annual Meeting Americas Hepato-
Pancreatico-Biliary Association, Eden Roc, Miami FL.
125. Surgical Management of GI Neurendocrine Tumors – 2014 Annual Scientific Meeting,
February 22nd 2014 – Southeastern Surgical Congress.
126. Invited Moderator – Pancreas and GI Session -Society of Surgical Oncology 67th Annual
Cancer Symposium – Phoenix, Az – March 15th 2014
127. Invited Speaker – Session Surgeon Directed Tumor Ablation - Society of Surgical
Oncology 67th Annual Cancer Symposium – Phoenix, Az – March 12th 2014 –
Advances of IRE in Pancreas.
128. Invited Speaker – Session Metastatic Colorectal Cancer – Synergy 2014 – A
Multidisciplinary Effect to Interventional Oncology November 15th 2014 – Irinotecan
Loaded Beads for the Treatment of Unresectable Colorectal Liver Metastasis
129. Invited Speaker – Session Pancreas – Synergy 2014 - A Multidisciplinary Effect to
Interventional Oncology November 16th 2014 – Resistance as a Measure of Successful Tumor
Electroporation during IRE of the Pancreas
CURRICULUM VITAE January 5th, 2014
63
130. Invited Disccussant – Western Surgical Association 2014 Annual Meeting, Indian Wells CA,
Nov 11th - Is Liver Transplantation Appropriate for Patients with Potentially Resectable de novo
Hilar Cholangiocarcinoma?
Regional:
131. Neoadjuvant Therapies in Esophageal Cancer. Central Baptist Hospital Oncology
Research Symposium, Lexington, KY. July 27th, 2006.
132. Surgical Management of Gastric and Distal Esophageal Lesions. Kentucky Medical
Association Annual Meeting, Kentucky Chapter, American College of Surgeons,
September 10th, 2003.
133. Advances in Hepatic Tumor Ablations. Central Surgical Association Louisville, KY.
March 2006.
134. Moderator, American Hepato-Pancreatico-Biliary Association Meeting, Hepatic and
Pancreatic Free Paper Session, Eden Roc Hotel, Miami, Florida, March 11th, 2006
135. Surgical Treatment of Malignant Liver Tumors: Resection and Ablative Options.
Southern Society of Clinical Surgeons, Louisville, KY, April 10th, 2006.
136. Optimal Management for Colorectal Cancer: Multi-disciplinary Care. Grand Rounds
Seymour, Indiana Cancer Center, October 5th, 2006.
137. Surgical Perspective in the Accurate Staging and Treatment of Stage III and Advanced
Staged Colon Cancer. Hurley Medical Center Tumor Board, Flint MI, Jan 17th, 2007
138. Surgical Perspective in the Accurate Staging and Treatment of Stage III and Advanced
Staged Colon Cancer. Saginaw Medical Specialist Multidisciplinary Meeting, Saginaw,
MI Jan 17th, 2007.
139. Surgical Perspective in the Accurate Staging and Treatment of Stage III and Advanced
Staged Colon Cancer. Utley Medical Center, Lafayette, IN, Jan 25th, 2007
140. Surgical Perspective in the Accurate Staging and Treatment of Stage III and Advanced
Staged Colon Cancer. Fort Wayne Medical Oncology Meeting, Fort Wayne, IN, Jan 25th
2007.
CURRICULUM VITAE January 5th, 2014
64
141. Optimal Surgical Management of Stage III and Stage IV colorectal cancer. Parkview
Hospital Tumor Board, Ft Wayne, IN May 2007.
142. Options for Localized Hepatocellular Cancer: Irreversible Electroporation. 2014
Hepatocellular Carcinoma: Advances and Challenges for Rapidly Increasing Malignancy.
University of Cincinnati, Cincinnati OH, Sept 27th, 2014.
Local:
143. Synchronous Colorectal Metastasis: Staged vs Simultaneous Resection? Surgical Grand
Rounds Memorial Sloan-Kettering Cancer Center, March 11th, 2002.
144. Surgical Management of Primary Liver Tumors. University of Louisville Department of
Surgery Grand Rounds, November 15th, 2002.
145. Cancer of the Pancreas. University of Louisville Department of Surgery Grand Rounds,
August 15th, 2003.
146. IntraOperative MRI Guided Liver Tumor Ablation. Second Annual IntraOperative MRI
Symposium. Norton Hospital Cancer Center, November 8th, 2003.
147. Surgical Therapy in Barrett’s Esophagus. Barrett’s Esophagus Symposium, Louisville,
KY. November 13th, 2004.
148. Tumors of the Pancreas: Diagnosis and Management. University of Louisville Surgical
Grand Rounds. Louisville, KY, February 21st, 2006.
149. Advances in the Surgical Treatment of Cancer. Second Annual Louisville Update in
Oncology, ASCO Review, Louisville, KY, July 15th, 2006.
150. Update on the Treatment of Liver Tumors. Kentucky Chapter American College of
Surgeons, Fall Meeting Sept 15th-16th, 2006.
151. Advances in Liver and Pancreatic Tumor Treatments. Norton Healthcare Perioperative
Symposium Sept 9th, 2006.
152. Management of Pancreatic Cancer. 6th Annual CEU Roundtable Conference for
Healthcare Professionals, October 12th, 2006.
153. University of Louisville Grand Rounds. Benign Liver Tumors and their Management.
October 20, 2006.
CURRICULUM VITAE January 5th, 2014
65
154. Gastroenterology/ Hepatology Teaching Conference. Advances in Barrett’s Esophagus
Basic Science Research. November 9th, 2006.
155. Pikeville Osteopathic School. Clinical Continutiy Lecture for 1st and 2nd year osteopathic
students. What is Cancer? How do you prevent it? November 17th, 2006.
156. Multimodality Gastrointestinal Cancers University of Louisville, James Graham Brown
Cancer Center. Surgical Managagement of Metastatic Gastrointestinal Cancers: Can it be
Curative? November 18th, 2006.
157. University of Louisville Department of Surgery Grand Rounds. Barrett’s Esophagus
August 24th, 2007.
158. University of Louisville, James Graham Brown Cancer Center, ASCO Review – Update
in Oncology, September 8, 2007. Advances in Upper Gastrointestinal and Hepato-
Pancreatico-Biliary Malignancies.
159. University of Louisville, Jewish Hospital, Advances in Laparoscopic Hepato Pancreatico
Biliary Surgery, September 14th, 2007. Outcomes in Laparoscopic Hepato Pancreatico
Biliary Surgery.
160. University of Louisville, James Graham Brown Cancer Center, 2nd Annual
Gastrointestinal and Hepato-Pancreatico-Biliary Multidisciplinary Conference, October
27th, 2007. Invited Speaker: Surgical Treatment in Pancreatic Cancer: Current State of the
Art.
161. Kentucky Chapter of the American College of Surgeons Meeting, November 3rd, 2007,
Louisville, Ky. Invited Speaker, Advances in Minimally Invasive Treatment of Liver
Tumors.
162. Norton Healthcare Endoscopy Symposium, November 15th, 2008, Louisville, Ky. Invited
Speaker, Advances in Esophageal Stenting for Esophageal Strictures: Benign and
Malignant.
163. First and Second Year Surgical Club University of Louisville, Olmstead, Louisville Ky,
October 14th 2013. Invited Speaker – Perspectives on a Career in Surgical Oncology.
164. Radiation Oncology Grand Rounds - Advances in locally advanced pancreatic cancer:
Optimal Palliation and Improved Quality of Life Time. Sept 26th, 2014.
Abstract Presentations:
CURRICULUM VITAE January 5th, 2014
66
1. Microbial Expression of the Human Estrogen Receptor Gene: Comparison of the Receptor
Protein with that of Human Breast Cancer. Poster Presentation, University of Louisville
Research Day, Louisville, KY, May 1992.
2. Twelfth Rib Resection: Preferred Therapy for Subphrenic Abscess in Selected Surgical
Patients. Oral Presentation, Louisville Surgical Society, Louisville, KY, February 1997.
3. Twelfth Rib Resection: Preferred Therapy for Subphrenic Abscess in Selected Surgical
Patients. Oral Presentation, Kentucky Chapter of the American College of Surgeons,
Lexington, KY, April 1997. Winner Resident Paper Competition.
4. Initial Neck Exploration in Untreated Hyperparathyroidism. Poster presentation,
Southeastern Surgical Congress, Tampa, FL, February 1999.
5. The Use of Intraoperative Methylene Blue in Parathyroid Resection. Poster Presentation,
Southeastern Surgical Congress, Tampa, FL, February 1999.
6. Initial Neck Explorations in Untreated Hyperparathyroidism. Oral Presentation, Louisville
Surgical Society, Louisville, KY, March 1999.
7. Special Problems in the Surgical Care of the Melanoma Patient. Oral Presentation,
Kentucky Chapter of the American College of Surgeons, Louisville, KY, May 1999.
8. Cost Comparison of Endoscopic Stenting versus Surgical Treatment for Unresectable
Cholangiocarcinoma. Martin RCG, Vitale GC, Reed DN, Larson GM, Edwards MJ,
McMasters KM. Poster presentation, Society of American Gastrointestinal Endoscopic
Surgeons, Atlanta, GA, March 29-April 1, 2000.
9. Optimal Gamma Probe Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a
Nationwide Multi-Institutional Study. Martin RCG, McMasters KM, Wong SL, Tuttle TM,
Edwards MJ. Oral Presentation, Kentucky Chapter of the American College of Surgeons,
Lexington, KY, March 2000. Louisville Surgical Society, Louisville, KY, April 2000.
Winner of the Resident Paper Competition.
10. A Microsatellite Marker for Colorectal Cancer Associated with the Human MSH2 Gene.
Martin RCG, Hunt LE, Eichenberger MR, Galandiuk S. Kentucky Chapter of the
American College of Surgeons, Lexington, KY, March 2000.
11. Do Facial Fractures Protect the Brain or Are They a Marker for Severe Head Injury?
Martin RCG, Cerrito P, Spain DA, Richardson JD. Oral Presentation, 108th Annual
Scientific Session of the Western Surgical Association, Dana Point, CA, November 12-15,
CURRICULUM VITAE January 5th, 2014
67
2000.
12. The Quality of Complication Reporting in the Surgical Literature. Martin RCG, Brennan
MF, Jaques DJ. Oral presentation, Southern Surgical Association, Hot Springs, VA,
December 2001.
13. Randomized Control Trials: Does Additional Training Increase Participation? Martin
RCG, Brennan MF, Polk HC Jr, Jaques DJ. Oral presentation, The American College of
Surgeons Clinical Congress, New Orleans, LA. October 2001.
14. Highest Isotope Count Does Not Predict Sentinel Node Positivity in all Breast Cancer
Patients. Martin RCG, Fey J, Borgen PI, Cody HS. Oral Presentation, Society of Surgical
Oncology, Washington, DC, March 15-18, 2001.
15. Solid-Pseudo Papillary Tumors of the Pancreas: A Surgical Enigma. Martin RCG,
Klimstra D, Brennan MF, Conlon KC. Poster presentation, Society of Surgical Oncology,
Washington, DC, March 15-18, 2001.
16. Extended Local Resection for Advanced Gastric Cancer: Increased Survival vs Increased
Morbidity? Martin RCG, Jaques DJ, Brennan MF, Karpeh M. Oral Presentation,
International Congress of Gastric Cancer, New York, N.Y., April 30-May 2, 2001.
17. Achieving R0 Resection for Locally Advanced Gastric Cancer: Is it Worth the Risk for
Multi-Organ Resection? Martin RCG, Brennan MF, Leung D, Karpeh, M. Poster
Presentation, Society for Surgery of the Alimentary Tract, Atlanta, GA, May 20-23, 2001.
18. Peritoneal Washings are not Predictive of Advanced Stage in Hilar Cholangiocarcinoma.
Martin RCG, Fong Y, Dermatteo RP, Blumgart LH, Jarnagin WR. Poster Presentation,
Society for Surgery of the Alimentary Tract, Atlanta, GA, May 20-23, 2001.
19. Synchronous Colorectal Liver Metastasis: Staged or Simultaneous Resection? Martin RCG,
Paty P, Fong Y, Grace AW, Cohen A, DeMatteo RP, Jarnagin W, Blumgart LH. Oral
Presentation, Paper Session I, 88th congress, American College of Surgeons, San Francisco
Oct 6th-10th, 2002.
20. Management of Colorectal Metastasis. Martin RCG, Brown Cancer Center Tumor
Conference, November 6th, 2002.
21. Surgical Exposure For Partial Hepatectomy: Is There a Difference in Complications From
Chevron versus Hockey Stisk Incision? Martin RCG, Cohen MS, Ben-Porat L, Goen M,
DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR . Poster Presentation, SSAT 2003
CURRICULUM VITAE January 5th, 2014
68
22. Martin RCG, Fong Y, Dematteo RP, Jarnagin WR, Blumgart LH. Major hepatectomy
with simultaneous pancreatectomy for advanced hepatobiliary cancer. Oral Presentation,
American Hepato-Pancreato-Biliary Congress, Feb 27-March2, 2003, Miami, FL.
23. Martin RCG, McMasters KM. The Use of Intra-Operative MRI with Ablation of Hepatic
Malignancies. Video Session, 56th Annual Cancer Symposium, March5-9, 2003, Los
Angeles CA.
24. Casos S, Martin RCG, McMasters KM. Advances in Hepatic Imaging. Video Session, 56th
Annual Cancer Symposium, March 5-9, 2003, Los Angeles CA.
25. Martin RCG, K Hughes, MA Doll, Q Lang, W Chow, J Lissowska, W Zatonski, N
Rothman and DW Hein. Genetic polymorphism (-102 C>T) in the human manganese
superoxide dismutase promoter region is frequent in Caucasians. Poster Presentation,
SNPs, Haplotypes, and Cancer: Applications in Molecular Epidemiology, American
Association of Cancer Research, September 13-17, 2003, Key Biscayne, FL
26. Martin RCG, K Hughes, MA Doll, Q Lang, W Chow, J Lissowska, W Zatonski, N
Rothman and DW Hein. Genetic polymorphism (-102 C>T) in the human manganese
superoxide dismutase promoter region is frequent in Caucasians. Poster Presentation,
James Graham Brown Cancer Center Retreat, September 17th, The Olmstead, Louisville,
KY.
27. Martin RCG, K Hughes, MA Doll, Q Lang, W Chow, J Lissowska, W Zatonski, N
Rothman and DW Hein. Association between the Manganese Superoxide Dismutase Gene
(-9 T>C) polymorphism and gastric cancer. Poster Presentation, James Graham Brown
Cancer Center Retreat, September 17th, The Olmstead, Louisville, KY.
28. Martin RCG, Hughes K, Doll MA, Lang Q, Chow W, Lissowska J, Zatonski W, Rothman
N, Hein DW. No Apparent Association between MnSOD (-9) and MnSOD (-102)
Genotypes and Risk of Gastric Cancer. American Association for Cancer Research, 95th
Annual Meeting, March 27-31, 2004, Orlando, Florida.
29. Li Y, Martin RC, Ellis SE, Ray M, Wo JM. A Novel External Esophageal Perfusion Rat
Model for Reflux Esophagitis. AGA Poster Session, Digestive Disease Week, New
Orleans, Louisiana, May 15-20, 2004 .
30. Martin RC, Edwards MJ, McMasters KM. Initial Experience with Hepatic Arterial Infusion
Pump Chemotherapy to the Liver. Oral Presentation. The Southwestern Surgical Congress,
Monterray, CA, April 18th-21st, 2004.
31. Martin RC, Wellhausen SR, Moehle DA, Martin AW, McMasters KM. Evaluation of
CURRICULUM VITAE January 5th, 2014
69
Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy. Oral
Presentation. 6th World Congress of the International Hepato-Pancreato-Biliary
Association, Washington, DC, June 2-6, 2004.
32. Martin RC, Casos S, Chao C, Wong SL, McMasters KM. Prolonged Survival after
Radiofrequency Ablation of Synchronous Colorectal Liver Metastases. Published ASCO
Proceedings. 2004 Annual Meeting of the American Society of Clinical Oncology, New
Orleans, LA, June 5-8, 2004.
33. Martin RCG, Li Y, Hein D. Expression of NAT1 and NAT2 in Human Normal Lung and
Bronchial Carcinoma. Third International Workshop on Arylamine N-Acetyltransferases,
Vancouver Canada, August 27-28th, 2004.
34. Martin RCG. The Big C: Cancer Prevention and Detection. The Third Annual Celebrating
Women 2004 Conference, Louisville, Ky. Sept 24th, 2004.
35. Martin RCG, Evaluation of Topical Recombinant Human Thrombin is a Phase 2 study in
patients Undergoing Hepatic Resection. Poster Presentation American College of Surgeons
Annual Meeting, San Francisco October 2005.
36. Helm CW, Martin RS III, Metzinger D, Parker L, Gordinier E, Edwards R. Hyperthermic
Intraperitoneal chemotherapy with surgery for recurrent ovarian carcinoma. Society of
Gynecologic Oncology Meeting, Palm Springs, CA, March 2006. Gyn Onc 2006, vol. 101,
Supplement 1, pg. 174-175.
37. Martin RCG, Lewis AM, Scoggins CR, Stromberg, AJ, Ellis SF, McMasters KM. Health
related quality of life: Return to baseline after major and minor liver resection.
International Hepato-Pancreato-Biliary Association 2006 Congress, Edinburgh, Scotland,
Sept 3rd-7th.
38. First Author Oral Presentation SAGES 2007 2007 Scientific Session, April 18-22, 2007,
Las Vegas, NV: The Use of Self Expanding Silicone Stents in Esophageal Cancer Care:
Optimal Pre-operative, Peri-operative, and Post-operative care.
39. First Author Oral Presentation AHPBA2007 Scientific Session, April 18-22, 2007, Las
Vegas, NV: Microwave Hepatic Tumor Ablation Results of ongoing Phase 2 Trial.
40. Senior Author Oral Presentation at the 115th Scientific Session, Western Surgical
Association, Boulder, CO, Nov 2007 Analysis of 900 Appendiceal Carcinoid Tumors with
a Proposal for a Staging System.
41. First Author Oral Presentaiton at the 115th Scientific Session, Western Surgical
CURRICULUM VITAE January 5th, 2014
70
Association, Boulder, CO, Nov 2007 Arterial and Venous Resection for Locally Advanced
Pancreatic Malignancies: Operative and Long-term Outcomes.
42. First Author Oral Presentation Society of Interventional Radiology Oncology Session,
Washington, DC March 19th, 2008: Transarterial Chemoembolization of Metastatic
Colorectal Carcinoma with Drug Eluting Beads: Multi-Institutional Study.
43. Senior Author Oral Presentation at the 116th Scientific Session, Western Surgical
Association, Sante Fe, N.M., Nov 11th, 2008. Evaluation of 2,537 Gastrointestinal Stromal
Tumors for a Proposed Clinical Staging System.
44. First Author Oral Presentation – Southern Surgical Assocation, December, 2008, The
Breakers, West Palm Beach, FL. Simultaneous vs. Staged Resection for Synchronous
Colorectal Cancer Liver Metastases.
45. First Author Oral Presentation at the 95th Annual Clinical Congress – American College of
Surgeons, October 12th, 2009, Chicago IL. Analysis of 6,747 Pancreatic Neuroendocrine
Tumors for a Proposed Staging System
46. First Author Oral Presentation – Southern Surgical Assocation, December, 2009, The
Homestead, Hot Springs VA. Laparoscopic Hepatic Lobectomy: Advantages of A
Minimally Invasive Approach.
47. Senior Author Oral Presentation – The Society of Surgical Oncology, March 6th, 2010,
Phase II comparison study of intraoperative autotransfusion for major oncologic
procedures.
48. Senior Author Oral Presentation – The Society of Surgical Oncology, March 6th, 2010,
Precision Hepatic Arterial Irinotecan Therapy in the Treatment of Unresectable
Intrahepatic Cholangiocarcinoma: Optimal Tolerance and Prolonged Overall Survival.
49. Senior Author Oral Presentation – The Central Surgical Association, March 13th, 2010,
Surveillance after Surgical Treatment of Melanoma: Futility of Routine Chest
Radiography.
50. First Author Oral Poster Presentation - Treatment of chemo naive colorectal liver
metastasis by using irinotecan drug eluting bead with concomiotant systemic fluorouracil
and oxaliplatin. 12th World Congress on Gastrointestinal Cancer, June 30th – July 3rd,
2010, Barcelona, Spain.
51. First Author Presentation - Management of diffuse hepatocellular cancer (≥ 10 lesions)
with doxorubicin-loaded DC Bead is a safe and effective treatment option. 12th Congress
CURRICULUM VITAE January 5th, 2014
71
of the Cardiovascular and Interventional Radiological Society of Europe, Valencia, Spain
October 2nd, 2010.
52. First Author Oral Presentation - Optimal technique of doxorubicin DC Bead in
Hepatocellular cancer: small bead vs. large bead, one vial vs. two vials, complete stasis vs.
partial stasis. 12th Congress of the Cardiovascular and Interventional Radiological Society
of Europe, Valencia, Spain October 2nd, 2010.
53. Senior Author Oral Presentation – The Southern Surgical Association, Dec 6th, 2010, The
Breakers, West Palm Beach, Fl. A Prospective Phase II Evaluation of Esophageal Stenting
for Neoadjuvant Therapy for Esophageal Cancer: Optimal Performance and Surgical Safety
54. First Author Oral Presentation – The American Surgical Association, April 15th, 2011, The
Boca Raton Resort and Spa, Boca Raton, Fl. Readmission Rates after Abdominal Surgery:
The Role of Surgeon, Primary Caregiver, Home Health, and Sub-acute Rehab
55. Senior Author Oral Presentation - Asian Pacific HPBA Congress, September 28th, 2011
Melbourne, Australia. Laparoscopic versus Open Resection of Hepatic Colorectal
Metastases.
56. First Author Oral Presentation - 65th Annual Cancer Symposium – Society of Surgical
Oncology, Orlando World Congress, Orlando, FL, March 23nd 2012. Image Guided
Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Improved Overall
Survival.
57. Senior Author Oral Presentation - 65th Annual Cancer Symposium – Society of Surgical
Oncology, Orlando World Congress, Orlando, FL, March 24nd 2012. A Deviation Based
Cost Modeling Analysis of Laparoscopic Versus Open Liver Resection.
58. Senior Author Oral Presentation - 69th Annual Meeting of the Central Surgical Association
at the Monona Terrace Convention Center in Madison, WI, March 1st, 2012. Laparoscopic
Versus Open Resection of Hepatic Colorectal Metastases
59. Senior Author Oral Presentation – 2012 AHPBA Annual Meeting, Eden Roc Resort,
Miami FL, March 7th 2012. Safety and Early Efficacy of Irreversible Electroporation for
Hepatic Tumors in Proximity to Vital Structures.
60. Senior Author Oral Presentation – 2012 Southern Surgical Association, The Breakers, Palm
Beach, FL, Dec 4th, 2012. The Assessment of Chemotherapy Response in Colorectal Liver
Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic
Residual Viable Tumor.
CURRICULUM VITAE January 5th, 2014
72
61. Senior Author Oral Presentation – 2013 Southeastern Surgical Congress, Jacksonville, FL,
Feb 12th, 2013. Evaluation of AFP Staging System for Hepatocellular Carcinoma in Non-
cirrhotic Patients.
62. Senior Author Oral Presentation – 66th Annual Society of Surgical Oncology Cancer
Symposium, New Harbor MD, March 8, 2013. Optimal Stroke Volume Variation in
Hepatic Resection: A replacement for standard central venous pressure monitoring.
63. Senior Author Oral Presentation – Central Surgical Association, Amelia Island, FL, March
15th, 2013. Clinical Evaluation of Somatostatin Use in Pancreatic Resections: Clinical
Efficacy or Limited Benefit?
64. Senior Author Oral Presentation – Western Surgical Association, Salt Lake Utah,
November 5th, 2013 - Single Stage Resection Combined with Microwave Ablation (MW)
for the Treatment of Bilobar Colorectal Cancer Metastases: Results from 201 Consecutive
Patients compared to two-stage Hepatectomy
65. First/ Senior Author Oral Plenary Presentation – 2014 Gastrointestinal Cancer Symposium
(giASCO) January 17th 2014 - Randomized Controlled Trial of Irinotecan Drug Eluting
Beads with Simultaneous FOLFOX and Bevacizamab for patients with Unresectable
Colorectal Liver-Limited Metastasis.
66. First/ Senior Author Poster Plenary Presentation – 2014 Gastrointestinal Cancer
Symposium (giASCO) January 17th 2014 - Randomized Controlled Trial of Irinotecan
Drug Eluting Beads with Simultaneous FOLFOX and Bevacizamab for patients with
Unresectable Colorectal Liver-Limited Metastasis.
67. First/ Senior Author Oral Presentation – 9th International Annual Symposium – Regional
Cancer Therapies – Feburary 15th-17th, 2014 Steamboat Springs, CO - Differences in
toxicity amongst drugs used in hyperthermic intraperitoneal chemotherapy
68. First/ Senior Author Oral Presentation – 9th International Annual Symposium – Regional
Cancer Therapies – Feburary 15th-17th, 2014 Steamboat Springs, CO - Quality of Life
(QOL) Improvement and Enhanced Efficacy with Hepatic Arterial Therapy of doxorubicin-
loaded beads(DEBDOX) in the treatment of liver metastases from Ocular Melanoma:
Results from a Phase I Trial.
69. First Author Oral Presentation – Americas Hepato-Pancreatico-Biliary Association –
February 22, 2014 – En Roc, Miami FL. Ongoing Clinical Trial - Drug-Eluting Bead,
Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with
Concomitant Systemic Gemcitabine and Cisplatin (Gem-Cis).
CURRICULUM VITAE January 5th, 2014
73
70. Senior Author Oral Presentation – Americas Hepato-Pancreatico-Biliary Association –
February 21st 2014 – En Roc, Miami FL. The role of hepatic artery lymph node (HALN) in
pancreatic adenocarcinoma: Prognostic factor or Surgical selection criteria.
71. Senior Author Oral Presentation – Americas Hepato-Pancreatico-Biliary Association –
February 21st 2014 – En Roc, Miami FL. Laparoscopic Hepatectomy Significantly
Shortens the Time to Postoperative Chemotherapy in Obese Patients Undergoing Major
Hepatectomies.
72. Senior Author Presentation – 2014 Annual Meeting Society of University Surgeons –
February 6th 2014 – San Diego, CA - Intra-operative Navigation of a 3-Dimensional
Needle Localization System for Precision of Irreversible Electroporation Needles in
Locally Advanced Pancreatic Cancer.
73. Senior Author Poster Presentation – 2014 Annual Scientific Meeting – February 24th, 2014
-Southeastern Surgical Congress -Restrictive Blood Transfusion Protocol in Liver
Resections Patients Reduces Blood Transfusions with No Increase in Patient Morbidity
74. Senior Author Poster Presentation – 2014 Annual Scientific Meeting – February 24th, 2014
– Southeastern Surgical Congress - GERD-Related Symptom Assessment in Subjects with
Malignant Dysphagia receiving Esophageal Stents.
75. Senior Author Oral Presentation – 2014 Central Surgical Association Meeting – 71st
Annual Meeting, March 7th 2014, Indianapolis IN. A Cost Analysis of a Pancreatic Cancer
Screening Protocol in High-Risk Populations.
76. Senior Author Oral Presentation – 2014 Central Surgical Association Meeting – 71st
Annual Meeting, March 7th 2014, Indianapolis IN. Borderline and Locally Advanced
Pancreatic Adenocarcinoma Margin Accentuation with Intra-Operative Margin
Accentuation.
77. First/ Senior Author Oral Presentation – Society of Surgical Oncology 67th Annual Cancer
Symposium – Phoenix, AZ – March 13th 2014 - Quality of Life (QOL) Improvement and
Enhanced Efficacy with Hepatic Arterial Therapy of doxorubicin-loaded beads(DEBDOX)
in the treatment of liver metastases from Ocular Melanoma: Results from a Phase I Trial.
78. First/ Senior Author Plenary Presentation – Society of Surgical Oncology 67th Annual
Cancer Symposium – Phoenix, AZ – March 14th 2014 - Randomized Controlled Trial of
Irinotecan Drug Eluting Beads with Simultaneous FOLFOX and Bevacizamab for patients
with Unresectable Colorectal Liver-Limited Metastasis.
CURRICULUM VITAE January 5th, 2014
74
79. Senior Author Oral Presentation - Society of Surgical Oncology 67th Annual Cancer
Symposium – Phoenix, AZ – March 14th 2014 Optimal Staging of Pancreatic
Neuroendocrine Tumors: Mandatory Grading using Ki67 Index and Mitotic Rate Increases
the Prognostic Accuracy of Disease-free Survival and Overall Survival
80. Senior Author Oral Presentation - Gastric-Esophageal Stenting for Malignant Dysphagia:
Results of Prospective Clinical Trial Evaluation of Long Term Gastro-Esophageal Reflux
and Quality of Life Related Symptoms – Western Surgical Association 2014 Annual
Meeting – Indian Wells, CA Nov 11th 2014
Recommended